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ABSTRACT 
  There is little information available about the relationship of newborn vitamin D status 
with pregnancy outcome and infant health.  The purpose of this cross-sectional study was to 
estimate the prevalence of vitamin D deficiency and insufficiency in newborns in the Saskatoon 
Health Region, identify risk factors for low neonatal levels of vitamin D, and determine whether 
any association exists between low levels of vitamin D and adverse pregnancy and neonatal 
outcomes.  
  The Newborn Vitamin D Study was conducted between December, 2011 and February, 
2012.  Sixty-five maternal-fetal dyads delivering in the Saskatoon Health Region were included 
in the study.  Mean cord blood vitamin D level was 64.1 nmol/L (standard deviation = 19.8 
nmol/L), which is in the insufficient range.  Cord blood vitamin D level was deficient (<50 
nmol/L) in 22% and insufficient (50-75 nmol/L) in 48% of the 65 newborns studied.  Simple 
linear regression indicated that low weight gain during pregnancy is significantly associated with 
low vitamin D levels (p = 0.04).  However, younger maternal age (p < 0.01) and urban area of 
residence (p = 0.09) were the strongest predictors of low cord blood vitamin D levels in a 
multiple linear regression model (R2 of 0.519, p = 0.003).  Cord blood vitamin D levels were not 
significantly associated with any pregnancy or neonatal outcomes. 
  Despite 85% of mothers reporting having taken a daily prenatal supplement, 70% of 
newborns in our study population had either an insufficient or deficient cord blood vitamin D 
status.  This suggests that prenatal supplements, which typically contain 400 IU of vitamin D, 
contain an inadequate dose of vitamin D to produce sufficient cord blood vitamin D levels in 
most newborns.  Further research is necessary to inform maternal vitamin D supplementation 
guidelines and to investigate the role of vitamin D in pregnancy outcomes and infant health. 
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CHAPTER 1: INTRODUCTION  
1.1 Introduction 
   In addition to its well-established role in bone health and calcium homeostasis, vitamin D 
is also a regulator of immune function and is implicated in predisposing to infection, 
autoimmune and cardiovascular diseases, mental illness, and cancer (McGrath, Saari et al. 2004; 
Nagpal, Na et al. 2005; Wang, Pencina et al. 2008).  In fact, it has been estimated that by 
optimizing vitamin D status in Canadians mortality could be reduced by 37,000 annually (a 
16.1% reduction) and reduce the annual economic burden by $14.4 billion (6.9%) (Grant, 
Schwalfenberg et al. 2010).  Vitamin D’s role in preventing adverse health outcomes may begin 
as early as the first trimester of intra-uterine development; low maternal vitamin D intake during 
pregnancy has been linked with increased risk of asthma and diabetes later in the offspring’s life 
(Camargo, Rifas-Shiman et al. 2007; Devereux, Litonjua et al. 2007; Erkkola, Kaila et al. 2009; 
Miyake, Sasaki et al. 2010; Krishnaveni, Veena et al. 2011).  However, few studies have 
assessed the relationship of newborn vitamin D levels with pregnancy outcome and neonatal 
health. 
  The prevalence of maternal vitamin D insufficiency and deficiency in Canada is between 
46-80% (Weiler, Fitzpatrick-Wong et al. 2005; Newhook, Sloka et al. 2009).  In Saskatchewan, 
the prevalence and health and economic burdens of maternal vitamin D deficiency are likely to 
be particularly high due to the population’s risk factors for low vitamin D status, including 
northern latitude ( 49 - 60°N), lack of sun exposure during the winter months, high prevalence of 
obesity, and high proportion of Aboriginal ethnicity (Camargo, Ingham et al. 2010; Dror, King et 
al. 2011).  However, no studies have investigated the vitamin D status of Saskatchewan mothers, 
and few studies anywhere have investigated maternal risk factors for having newborns with low 
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levels of vitamin D.   
 The lack of consensus on guidelines for vitamin D supplementation during pregnancy 
may be contributing to the lack of adequate maternal vitamin D supplementation in Canada and 
abroad (Hypponen and Boucher 2010).  Different recommendations by the Canadian Pediatric 
Society, the Endocrine Society and Health Canada may cause confusion among mothers and 
health care practitioners alike (Canadian Pediatric Society 2007; Health Canada 2010; Holick, 
Binkley et al. 2011).  Research that examines the pregnancy and neonatal outcomes associated 
with newborn vitamin D status may aid in determining how much supplementation is necessary 
for healthy maternal and fetal development and thus help guide development of consensus 
guidelines for maternal vitamin D supplementation. 
  The prevalence of newborn vitamin D deficiency ranges from 11 - 93%, depending on 
the definition of deficiency used and the population studied (Maghbooli 2007; Bowyer, Catling-
Paull et al. 2009).  Because vitamin D crosses the placenta, the vitamin D level of the newborn is 
entirely dependent on the maternal vitamin D level (Hillman and Haddad 1974).  Therefore, a 
high prevalence of vitamin D deficiency or insufficiency in pregnant women correlates with a 
correspondingly high prevalence of vitamin D deficiency or insufficiency in newborns.  
However, the clinical significance of low newborn vitamin D levels has not been established. 
Although some studies indicate low neonatal levels of vitamin D may be associated with adverse 
neonatal outcomes (Belderbos 2011; Camargo, Ingham et al. 2011), it is unknown if low levels 
of vitamin D may harm infants or whether they are simply reflective of a lower vitamin D 
requirement. 
 This research aimed to estimate the prevalence of low neonatal levels of vitamin D in the 
Saskatoon Health Region, identify maternal risk factors for low neonatal vitamin D levels, and 
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examine the relationship between low neonatal levels of vitamin D and adverse pregnancy and 
neonatal outcomes.  Information generated by this research will help identify socio-demographic, 
obstetric and personal health factors that combine to influence vitamin D levels in the newborn, 
and will help empower pregnant women to optimize their vitamin D status and thereby 
contribute to improving the long term health of their offspring.  These findings will help to 
inform future studies in order to prevent adverse effects of low levels of vitamin D in utero and 
in childhood. 
 
1.2 Objectives 
1) To estimate the prevalence of vitamin D sufficiency, insufficiency and deficiency in newborns 
delivered in the Saskatoon Health Region.   
2) To identify associations between neonatal levels of vitamin D based on cord blood samples 
and socio-demographic, obstetric, and personal health factors in this population.   
3) To identify associations between neonatal levels of vitamin D based on cord blood samples 
and obstetric and neonatal outcomes such as method of delivery, delivery complications, infant 
weight, infant length, infant head circumference, Apgar scores, and illness at birth. 
 
1.3 Hypotheses 
Hypothesis 1: The majority of newborns in the Saskatoon Health Region will have deficient or 
insufficient cord blood levels of vitamin D. 
Hypothesis 2: Risk factors for low levels of D in newborns will include dark skin pigmentation, 
high pre-pregnancy BMI, and a lack of vitamin D supplementation.   
Hypothesis 3: Low levels of cord blood vitamin D will be associated with Cesarean delivery, 
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increased risk of delivery complications, low birth weight, low birth length, smaller head 
circumference, low Apgar scores, and increased risk of illness at birth. 
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2.  LITERATURE REVIEW 
2.1 Vitamin D Physiology 
2.1.1 Biochemistry of Vitamin D 
  The term “vitamin D” is in fact a misnomer.  Whereas true vitamins are ingested only 
through exogenous supplementation, vitamin D may be produced endogenously and moves to 
other areas in the body to exert its action.  Vitamin D is therefore a hormone, not a vitamin, but it 
is referred to as a vitamin due to current convention.   
  There are two forms of vitamin D.  Vitamin D2 (ergocalciferol) is derived from the 
ultraviolet irradiation of plant ergosterol, and vitamin D3 (cholecalciferol) is found in fish oils 
and is made in the skin.  Vitamin D3 is produced from 7-dehydrocholesterol in skin exposed to 
ultraviolet B (UVB) radiation (Holick 2006), and both vitamins D2 and D3 may be ingested 
through the diet or through supplementation (Holick 2007).  In this thesis, vitamin D will refer to 
both vitamin D2 and D3. 
  Vitamin D is hydroxylated in the liver and becomes 25(OH)D, or calcidiol, the primary 
circulating form of vitamin D.  25(OH)D may be converted to 1,25(OH)2D (calcitriol), the active 
form of vitamin D, by 1-alpha hydroxylase (CYP27B1) in the kidneys and other organs.  The 
production of 1,25(OH)2D in the kidney is regulated by plasma parathyroid hormone levels as 
well as serum calcium and phosphorus levels (Holick 2007).  1,25(OH)2D is broken down into its 
inactive metabolite by 24-hydroxylase (CYP24).  Negative feedback aids in regulating 
1,25(OH)2D levels, as 1,25(OH)2D inhibits renal 1-alpha hydroxylase and stimulates 24-
hydroxylase, and this maintains circulating levels within a limited range (Aranow 2011).  As 
well, excess vitamin D in the skin is broken down by sunlight, inhibiting the production of 
excessive vitamin D after prolonged sun exposure. 
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  More than 80% of the vitamin D requirement is derived from cutaneous synthesis (Holick 
2007).   Vitamin D can also be ingested through supplementation or through vitamin D-rich 
foods, including oily fish such as salmon, mackerel and sardines, some fish oils such as cod liver 
oil, egg yolk, and vitamin D-enriched foods (milk, infant formula, cereal, orange juice, yogurt 
and margarine) (Holick 2006).  However, dietary intake alone, including fortified foods, is 
unlikely to provide the daily recommended quantity of vitamin D to prevent insufficiency. 
Supplements are usually required to reach the minimum recommended daily intake of vitamin D, 
especially during the winter months (Holick 2006). 
 
2.1.2 Vitamin D in Bone Health 
2.1.2.1 Normal Vitamin D Physiology  
  Calcitriol increases levels of ionized calcium in blood by binding to the vitamin D 
receptor (VDR).  In the intestine, the calcitriol-VDR complex acts as a transcription factor for 
the expression of transport proteins involved in calcium absorption (Bouillon 2003), and an 
increase in intestinal absorption of calcium results.  In the kidney, calcitriol increases renal 
tubular reabsorption of calcium, and in bone, calcitriol indirectly stimulates osteoclast action to 
increase calcium release into blood.  Calcitriol also acts directly on the parathyroid gland to 
decrease parathyroid hormone (PTH) production and indirectly decreases PTH by increasing 
serum calcium concentration (Holick 2006). 
  Vitamin D is primarily responsible for regulating absorption of calcium and phosphorus 
from the intestine.  Low levels of vitamin D result in only 10% to 15% of dietary calcium and a 
low level of dietary phosphorus being absorbed. However, when vitamin D levels are sufficient, 
30% to 40% of dietary calcium and a higher level of phosphorus are absorbed (Heaney, Dowell 
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et al. 2003; Holick 2007).  Low levels of vitamin D result in insufficient calcium absorption to 
maintain calcium homeostasis, and low serum calcium stimulates PTH release.  PTH increases 
serum calcium by acting on bone to increase calcium release, acting on the kidney to increase 
renal tubular calcium reabsorption, and increasing formation of calcitriol (Holick 2006). 
 
2.1.2.2 Effects of Low Vitamin D on Bone Health  
  Chronic, severe vitamin D deficiency results in impaired calcium absorption.  Low 
calcium stimulates the parathyroid gland resulting in secondary hyperparathyroidism, which 
allows the body to avoid hypocalcemia by mobilizing bone stores of calcium.  In infants and 
adolescents, these bone stores of calcium occasionally cannot be released quickly enough to meet 
the demand during periods of rapid growth, and this may result in hypocalcemic seizures or 
tetany (Narchi, El Jamil et al. 2001; Ladhani, Srinivasan et al. 2004).  In school-aged children, 
chronic mobilization of calcium from bone is usually sufficient to maintain normal serum 
calcium, but demineralization and subsequent deformity of the bone can result in rickets 
(Ladhani, Srinivasan et al. 2004).  Bone breakdown is also the reason that low vitamin D in 
pregnancy and in childhood may impair the attainment of peak bone mass in children (Cooper, 
Javaid et al. 2005).  The same process in adults may result in bone pain, proximal muscle 
weakness, osteomalacia, osteoporosis, and increased risk of fractures (Exton-Smith, Hodkinson 
et al. 1966; Passeri, Pini et al. 2003). 
 
2.1.3 Nonskeletal Roles of Vitamin D 
  The presence of the vitamin D receptor in a wide variety of nonskeletal organs and 
tissues suggests that vitamin D likely plays a role in a many physiological processes.  A role for 
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vitamin D has been implicated in cardiovascular health (Wang, Pencina et al. 2008), autoimmune 
disease (Munger, Zhang et al. 2004), cancer (Chang, Smedby et al. 2005), neurological 
development (Eyles, Burne et al. 2011) and immune function (Aranow 2011).  As well, vitamin 
D levels have been associated with preeclampsia (Halhali, Tovar et al. 2000), dermatologic 
diseases (Kragballe, Barnes et al. 1998), obesity (Gilbert-Diamond 2010), and mental health, 
specifically schizophrenia (McGrath, Saari et al. 2004) and seasonal affective disorder (Gloth, 
Alam et al. 1999).  Vitamin D receptor ligands have been implicated in; “inflammation 
(rheumatoid arthritis, psoriatic arthritis), dermatological indications (psoriasis, actinic keratosis, 
seborrheic dermatitis, photoaging), osteoporosis (postmenopausal and steroid-induced 
osteoporosis), cancers (prostate, colon, breast, myelodysplasia, leukemia, head and neck 
squamous cell carcinoma, and basal cell carcinoma), secondary hyperparathyroidism, and 
autoimmune diseases (systemic lupus erythematosus, type I diabetes, multiple sclerosis, and 
organ transplantation).” (Nagpal, Na et al. 2005) 
  The mechanisms by which vitamin D exerts its nonskeletal effects are manifold.  
Calcitriol directly or indirectly controls more than 200 genes.  It is involved in the regulation of 
cellular differentiation, apoptosis, proliferation and angiogenesis (Nagpal, Na et al. 2005).  It 
increases myocardial contractility (Zittermann 2006), inhibits renin synthesis (Li 2003) and is 
involved in insulin production (Chiu, Chu et al. 2004).  It also acts as an immunomodulator 
(Penna, Roncari et al. 2005), as it dampens systemic inflammatory responses through functional 
vitamin D receptors present on all major immune cells.  In short, researchers are only beginning 
to elucidate the role of vitamin D in physiology, and additional research is necessary before the 
importance of vitamin D supplementation is fully understood.  
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2.1.4 The Vitamin D Receptor 
  The vitamin D receptor (VDR) is a steroid hormone receptor that binds calcitriol and acts 
as a transcription factor during gene expression (Holick 2006).  After the VDR is bound to 
calcitriol, the complex dimerizes with the retinoid X receptor (RXR).  The calcitriol-VDR-RXR 
heterodimer translocates into the nucleus and binds to vitamin D responsive elements in the 
promoter regions of vitamin D responsive genes, inducing their expression (Aranow 2011). 
  The VDR  is expressed in many organs including those not typically involved in calcium 
homeostasis or bone metabolism, such as the placenta, brain, gonads, heart, lung, prostate, skin, 
breast, pancreas, small intestine, colon, immune system and vascular wall (Holick 2007).  The 
placenta, brain, lymph nodes and skin also express alpha-1 hydroxylase, and they are therefore 
capable of producing calcitriol as an autocrine hormone (Hewison 2000; Eyles, Smith et al. 
2005).  The presence of the VDR in this wide variety of tissue types suggests that vitamin D’s 
role in physiology is more multifaceted than previously recognized.  Further research is 
necessary to confirm the nature of vitamin D’s interaction with these tissue types. 
  Mutations in the VDR have been associated with many clinical outcomes.  VDR genetic 
mutations can confer susceptibility to bone demineralization, particularly in the context of other 
risk factors such as age, suboptimal calcium intake, and physical inactivity (Viitanen AM 1996; 
Gong, Stern et al. 1999; Ralston 2003).  Genetic mutations in the VDR have also been associated 
with increased risk of developing cancers (Slattery, Neuhausen et al. 2004; Uitterlinden, Fang et 
al. 2004; John, Schwartz et al. 2005) and type 1 diabetes mellitus (McDermott, Ramachandran et 
al. 1997; Slattery, Neuhausen et al. 2004).  Vitamin D and its receptor may both play a role in 
disease prevention and the maintenance of skeletal and extraskeletal health. 
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2.1.5 Vitamin D Genetics 
  Mutations in the proteins involved in vitamin D absorption, metabolism, and excretion 
may affect serum vitamin D levels and therefore susceptibility to vitamin D-related disease 
outcomes.  The best-studied mutations effecting serum 25(OH)D levels are single nucleotide 
polymorphisms in the vitamin D receptor (VDR), the group-specific component of the vitamin D 
binding protein (VDBP), and the cytochrome P450s involved in vitamin D metabolism.  The 
single nucleotide polymorphisms (SNPs) in the VDBP most strongly associated with serum 
vitamin D levels include rs4588 and rs7041 (McGrath, Saha et al. 2010).  The former SNP is 
associated with increased 25(OH)D levels while the latter is  associated with decreased vitamin 
D levels.  The SNP rs2228570 (formerly rs10735810) in the VDR is associated with increased 
vitamin D concentrations.  While the SNP rs10877012 in CYP27B1 (also known as 1-alpha 
hydroxylase) was found to be significantly associated with vitamin D levels in two studies, the 
direction of the association differed between the studies (McGrath, Saha et al. 2010).  
  The mechanism of action for SNP influence on vitamin D levels is poorly understood 
(McGrath, Saha et al. 2010).  However, it is possible that individuals with different vitamin D-
related genotypes require varying levels of vitamin D to optimize their vitamin D status.  It is 
also likely that genotype plays a role in susceptibility to vitamin D-related disease outcomes. 
More studies are required to investigate the relationship between SNPs in the VDR and VDBP, 
vitamin D levels, and disease pathogenesis. 
  Evidence that SNPs in vitamin D-related proteins are related to clinical outcomes is 
mounting.  SNPs in the VDR have been linked with multiple primary melanoma (Mandelcorn-
Monson, Marrett et al. 2011), prostate cancer (John, Schwartz et al. 2005), colorectal cancer 
(Slattery, Neuhausen et al. 2004), Alzheimer’s disease (Lehmann, Refsum et al. 2011), type 1 
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diabetes mellitus (McDermott, Ramachandran et al. 1997; Slattery, Neuhausen et al. 2004), 
multiple sclerosis (Agliardi 2011), and RSV infection in children (Kresfelder, Janssen et al. 
2011).  VDR genotype has been associated with decreased bone mineral density and increased 
fracture risk in several studies (Viitanen AM 1996; Feskanich, Hunter et al. 1998; Gong, Stern et 
al. 1999; Ralston 2003), and maternal VDR genotype has been associated with increased risk of 
infants being born small for gestational age (Bodnar, Catov et al. 2010).  SNPs in the VDBP 
have been associated with breast cancer (Anderson, Cotterchio et al. 2011), inflammatory bowel 
disease (Eloranta, Wenger et al. 2011), asthma (Li, Jiang et al. 2011) and COPD (Wood, 
Bassford et al. 2011).  A SNP in CYP2R1 (also called 25-hydroxylase) was associated with 
increased risk of asthma (Pillai, Iqbal et al. 2011).  The existing body of evidence therefore 
favours the role of vitamin D in the pathophysiology of many diseases.  However, further studies 
must be conducted to clarify the role of genotype in disease susceptibility.  
 
2.1.6 Definition of Vitamin D Deficiency  
  Although 1,25(OH)2D is the active form of vitamin D, due to a tight regulation of its 
production as well as a relatively short half-life (4–6 hours), it is not a good indicator of vitamin 
D status (Papandreou, Malindretos et al. 2010).  As well, 1,25(OH)2D may be normal or even 
elevated in those with vitamin D deficiency due to secondary hyperparathyroidism and does not 
accurately reflect vitamin D stores (Holick, Binkley et al. 2011).  Serum or plasma 25(OH)D has 
a half-life of two to three weeks and is the major circulating form of vitamin D (Holick, Binkley 
et al. 2011).  25(OH)D is therefore the most appropriate biochemical marker of vitamin D status 
(Papandreou, Malindretos et al. 2010).
   
  The optimal level of vitamin D for bone health was determined to be the one at which a 
12 
 
minimal level of PTH was released and a maximal level of calcium was absorbed.  PTH levels 
plateau at their minimum level at a 25(OH)D concentration of 75 nmol/L (Chapuy, Preziosi et al. 
1997; McKenna and Freaney 1998; Heaney 2004; Holick, Siris et al. 2005) and serum 25(OH)D 
levels greater than 75 nmol/L may be required to maximize intestinal calcium absorption 
(Heaney, Dowell et al. 2003).   A 25(OH)D level greater than 75 nmol/L may also be necessary 
to prevent secondary hyperparathyroidism-induced skeletal conditions (van der Wielen, Lowik et 
al. 1995; Feskanich, Willett et al. 2003).  Based on this and similar evidence, vitamin D 
sufficiency, insufficiency and deficiency have been defined by the Endocrine Society as 
25(OH)D levels greater than 75 nmol/L, 50-75 nmol/L, and less than 50 nmol/L, respectively 
(Holick, Binkley et al. 2011).  Vitamin D intoxication occurs when 25(OH)D levels exceed 374 
nmol/L (Holick 2007) (Table 1).  Despite these proposed recommendations for categorizing 
vitamin D status, there is still debate about the correct definition of vitamin D deficiency in both 
adults and children. 
 There are no age-specific reference ranges for serum vitamin D status.  The Endocrine 
Society definitions of vitamin D sufficiency, insufficiency and deficiency are the same for 
children as they are for adults (Holick, Binkley et al. 2011).  Some research supports these 
definitions, as an inverse relationship has been demonstrated between 25(OH)D and PTH levels 
in children and adolescents (Cheng, Tylavsky et al. 2003; Abrams, Griffin et al. 2005).  
Furthermore, PTH levels plateau at 25(OH)D levels >80 nmol/L in adolescents (Guillemant, 
Taupin et al. 1999).   However, little is known about the normal 25(OH)D range in neonates, 
infants, and children.  In his review article on the role of vitamin D in child and adolescent 
health, Daniel Roth argues that because umbilical cord 25(OH)D samples usually contain 50-
60% of the maternal 25(OH)D concentration (Waiters, Godel et al. 1999), “it might be inferred 
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that normal neonatal concentration is >40 nmol/L”(Roth 2007).  He notes that additional research 
on the clinical outcomes of vitamin D deficiency in neonates is necessary to establish age-
specific reference ranges (Roth 2007).  Until new information is available, the acceptable 
vitamin D levels for children will remain the same as they are for adults. 
Table 1. Vitamin D Status Based on Serum 25(OH)D Level * 
Vitamin D Status Serum 25(OH)D 
Deficient <50 nmol/L (<20 ng/mL) 
Insufficient 50-75 nmol/L (20-30 ng/mL) 
Sufficient >75 nmol/L (>30 ng/mL) 
Intoxication >374 nmol/L (150 ng/mL) 
 
*25(OH)D refers to calcidiol.  Vitamin D status according to the Endocrine Society (Holick, 
Binkley et al. 2011) 
 
 
2.1.7 Risk Factors for Low Levels of Vitamin D 
  Any factor that limits the cutaneous synthesis of vitamin D is a risk factor for having 
insufficient or deficient serum levels of vitamin D.  Increased clothing coverage, regular 
sunscreen use, and limited time outdoors are therefore risk factors for vitamin D insufficiency or 
deficiency (Dror, King et al. 2011).  During the winter months, there is insufficient UVB 
irradiation from sunlight to stimulate cutaneous synthesis of vitamin D, particularly in people 
living above 42 degrees latitude (Webb 1988).  As well, melanin acts as a natural sunscreen in 
those with darker skin tones, decreasing the cutaneous production of vitamin D by as much as 
99%, similar to wearing sunscreen with a sun protection factor of 15 (Clemens 1982 ; Matsuoka 
1987; Holick 2006).  Consequently, northern latitude, winter season, and darker skin tone are 
also risk factors for vitamin D insufficiency and deficiency.   
  Other risk factors for vitamin D deficiency and insufficiency include malabsorptive 
syndromes (Lo, Paris et al. 1985; Koutkia, Lu et al. 2001), lack of supplementation (Delvin, 
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Salle et al. 1986), high body mass index (BMI) (Bell, Epstein et al. 1985; Wortsman, Matsuoka 
et al. 2000; Arunabh, Pollack et al. 2003; Snijder, van Dam et al. 2005), certain medications 
(Pascussi, Robert et al. 2005), age (MacLaughlin and Holick 1985; Holick, Matsuoka et al. 
1989), socioeconomic status (Laitinen, Rasanen et al. 1995; Pehlivan, Hatun et al. 2003; 
Rasanen, Kronberg-Kippila et al. 2006), and genetic mutations in the vitamin D receptor or the 
vitamin D binding protein (McGrath, Saha et al. 2010).   
  When cutaneous synthesis does not produce adequate levels of vitamin D, the body relies 
on absorption of vitamin D from the intestine.  Malabsorptive syndromes, such as inflammatory 
bowel disease, celiac disease or cystic fibrosis, decrease the ability of the intestine to absorb any 
ingested vitamin D (Lo, Paris et al. 1985; Koutkia, Lu et al. 2001).  A lack of dietary vitamin D 
makes less vitamin D available for absorption by the intestine, and medication use, particularly 
anticonvulsants, corticosteroids and rifampin, can interfere with its subsequent metabolism (Bell, 
Epstein et al. 1985; Pascussi, Robert et al. 2005).  Metabolized vitamin D is less physiologically 
available to those with a high BMI, as the fat-soluble vitamin becomes sequestered in the fat and 
results in lower serum vitamin D levels (Bell, Epstein et al. 1985; Wortsman, Matsuoka et al. 
2000; Arunabh, Pollack et al. 2003; Snijder, van Dam et al. 2005).  Increased age results in lower 
vitamin D levels in both children (Roth, Martz et al. 2005) and the elderly (MacLaughlin and 
Holick 1985; Holick, Matsuoka et al. 1989), and socioeconomic status, reflected by education 
level, occupation and household income, is a risk factor for low levels of vitamin D because low 
socioeconomic status families are less likely to consume sufficient vitamin D in their diets 
(Laitinen, Rasanen et al. 1995; Rasanen, Kronberg-Kippila et al. 2006).  Finally, genetic 
mutations in the vitamin D receptor and vitamin D binding protein play a role in modulating 
vitamin D levels (McNally, Leis et al. 2009), though the mechanism of this is poorly understood 
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(McGrath, Saha et al. 2010).  
  Ethnicity is also a risk factor for low serum levels of vitamin D (Camargo, Ingham et al. 
2010).  Although skin pigmentation likely accounts for much of the observed ethnic differences, 
genetic and environmental differences among ethnic groups may also contribute to lower serum 
25(OH)D levels and these warrant further study.  
 
2.1.7.1 Risk Factors for Low Levels of Vitamin D in Newborns 
  Because vitamin D is transported across the placenta, newborns are entirely dependent on 
their mothers for vitamin D.  Therefore, through contribution to low maternal vitamin D status, 
the risk factors listed above are also risk factors for low vitamin D status in the newborn.  Other 
established risk factors for vitamin D deficiency in infancy include maternal vitamin D 
deficiency and breastfeeding without supplementation, as human milk contains only 20 IU/L of 
vitamin D (Canadian Pediatric Society 1988).  Longer gestational age and younger maternal age 
were associated with low cord blood vitamin D levels in a New Zealand study involving 929 
newborns (Camargo, Ingham et al. 2010), and an Australian study involving 901 newborns also 
found an association between low newborn vitamin D and younger maternal age (Bowyer, 
Catling-Paull et al. 2009). Longer gestational age provides a longer period for a fetus to draw 
upon its mother’s declining vitamin D levels, and lower maternal age may lead to less sun 
exposure or less compliance in taking prenatal vitamins (Camargo, Ingham et al. 2010).  
However, these findings require replication and further investigation before they are accepted as 
risk factors for low levels of vitamin D in newborns. 
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2.2 Vitamin D in Pregnancy  
2.2.1 Guidelines for Vitamin D Supplementation in Pregnancy    
  There are no consensus guidelines for vitamin D supplementation during pregnancy.  The 
Canadian Pediatric Society (CPS) recommends vitamin D supplementation of 2000 IU/day 
during pregnancy and lactation (Canadian Pediatric Society 2007), while Health Canada 
recommends 600 IU/day for pregnant and breast-feeding women (Health Canada 2010).  The 
Health Canada guidelines are based on the 2010 U.S.  Institute of Medicine report, which is 
primarily intended for food manufacturers, while the CPS guidelines are based a thorough 
literature review and are intended for clinicians.   
  Meanwhile, the National Institute for Health and Clinical Excellence in the United 
Kingdom recommends 400 IU/day of vitamin D during pregnancy (National Institute for Health 
and Clinical Excellence 2008), the World Health Organization recommends 200 IU/day (World 
Health Organization 2004), and the Endocrine Society recommends 600 IU/day (Holick, Binkley 
et al. 2011).  However, the Endocrine Society also recognizes that doses of up to 1500 – 2000 
IU/day may be required to maintain sufficient serum vitamin D levels (>75 nmol/L) during 
pregnancy and lactation (Holick, Binkley et al. 2011). 
  Recent studies have also suggested the need for much higher intakes during pregnancy, 
with one suggesting that supplementation of 4000 IU/day was safe and most effective in 
achieving sufficiency in pregnant mothers and their offspring (Hollis, Johnson et al. 2011), and 
another showing that doses of up to 10,000 IU/day for five months in pregnancy did not elevate 
levels into the toxic range (Hollis and Wagner 2004).   Studies have also indicated that doses of 
400 IU/day are inadequate to achieve sufficient serum vitamin D levels in mothers (Dror, King et 
al. 2011) and newborns (Bodnar, Simhan et al. 2007).  The author of a British review article 
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concluded that, “The lack of unified advice on vitamin D supplementation of pregnant mothers 
in the UK hinders the implementation of primary prevention strategies and is likely to leave 
some deficient mothers without supplementation (Hypponen and Boucher 2010).” The same 
could be said of Canada. 
  The Endocrine Society Clinical Practice Guidelines suggest that pregnancy and lactation 
are an indication for 25(OH)D screening (Holick, Binkley et al. 2011), but the British Journal of 
Nutrition argues that given the prevalence of deficiency and the cost of the assay, it would be 
much cheaper and more effective to have universal guidelines for Vitamin D supplementation 
during pregnancy than screening every pregnant woman for deficiency (Hypponen and Boucher 
2010). 
 
2.2.2 Prevalence of Vitamin D Insufficiency and Deficiency in Pregnancy 
  This review will use the definition of vitamin D insufficiency and deficiency espoused by 
the Endocrine Society, which defines vitamin D sufficiency as a serum vitamin D level of >75 
nmol/L, insufficiency as 50-75 nmol/L, and deficiency as <50 nmol/L (Holick, Binkley et al. 
2011).  Though the definitions of vitamin D deficiency and insufficiency differ among studies, 
most conclude that low levels of vitamin D are prevalent among pregnant mothers (Kazemi A 
2009; Camargo, Ingham et al. 2010; Dror, King et al. 2011).  In Britain’s Avon Longitudinal 
Study of Parents and Children, 90% of the 10,000 white pregnant mothers had 25(OH)D 
concentrations in the deficiency range (<50 nmol/l) during winter and spring while 28% were 
seriously deficient (<25 nmol/l) (Golding, Pembrey et al. 2001).  In Oakland, California, 54% of 
275 mothers and 90% of their neonates had insufficient serum 25(OH)D levels (<75 nmol/L) 
over a one year period (Dror, King et al. 2011).  Similar studies in France (Madelenat, Bastian et 
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al. 2001), India (Sachan 2005), Iran (Kazemi A 2009), China (Specker, Ho et al. 1992) and New 
Zealand (Camargo, Ingham et al. 2010) have shown that maternal serum levels of vitamin D are 
frequently deficient, and a review article on serum vitamin D levels in pregnancy found that 35 
of 76 studies reviewed had mean or median vitamin D levels below 35 nmol/L (Schroth, Lavelle 
et al. 2005).   
  In Canada, several studies have assessed the vitamin D status of pregnant mothers.  In 
Vancouver, 24% and 65% of 336 multiethnic pregnant women had deficient (<50 nmol/L) and 
insufficient (<75 nmol/L) serum levels of vitamin D, respectively (Li 2011).  In Newfoundland 
and Labrador, a study of 50 pregnant women found that 38% of pregnant women had insufficient 
(50-75 nmol/L) and 42% had deficient (<50 nmol/L) levels of vitamin D (Newhook, Sloka et al. 
2009).  In the Northwest Territories, a study of 121 pregnant mothers revealed that the mean 
vitamin D level for Caucasian and Native Indian mothers was insufficient (< 75nmol/L), while 
the mean vitamin D level for Inuit mothers was deficient (<50 nmol/L) (Waiters, Godel et al. 
1999).  Three small studies in Northern Manitoba (n= 32, 35, 37) found that the median serum 
vitamin D concentrations in pregnant mothers was seriously deficient (<25 nmol/L) (Smith 
2000), and in Montreal, a small study (n = 27) of mothers with twin pregnancies found a mean 
serum vitamin D concentration in the deficiency range (<50 nmol/L) (Reddy, Norman et al. 
1983).  Finally, a Winnipeg study (n = 50) found that 46% of mothers who had delivered within 
the past 48 hours were deficient (<37.5 nmol/L) (Weiler, Fitzpatrick-Wong et al. 2005).  
Therefore, existing research indicates that vitamin D deficiency in pregnant mothers is prevalent 
in Canada.   
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2.2.3 Outcomes of Vitamin D Sufficiency, Insufficiency and Deficiency in Pregnancy 
  While one 2011 review article concluded that there is insufficient evidence to suggest 
that low vitamin D levels in the first trimester are associated with adverse pregnancy and 
neonatal outcomes (Nassar, Halligan et al. 2011), a second 2011 review article concluded that, 
“Recent evidence supports a role of maternal vitamin D status, particularly early in pregnancy, in 
modulating the risk of pregnancy complications and in sustaining fetal growth, bone 
development, and immune maturation” (Dror 2011).  Though existing evidence on the role of 
maternal vitamin D in pregnancy, neonatal, and child health outcomes is sparse and sometimes 
conflicting, it suggests that maternal vitamin D supplementation is required to prevent adverse 
health outcomes in mothers, infants and children. 
 
2.2.3.1 Maternal Effects of Gestational Vitamin D Deficiency 
Low levels of vitamin D throughout pregnancy have been associated adverse health 
outcomes for mothers, including preeclampsia (Bodnar, Catov et al. 2007), gestational diabetes 
(GDM) (Soheilykhah, Mojibian et al. 2010), intrahepatic cholestasis of pregnancy (Wikstrom 
Shemer and Marschall 2010), periodontal disease (Dietrich, Joshipura et al. 2004; Boggess, 
Espinola et al. 2011), Caesarean section (Merewood, Mehta et al. 2009) and HIV progression 
and mortality (Mehta, Giovannucci et al. 2010).  This thesis will not cover maternal outcomes of 
vitamin D deficiency in detail as its focus is on neonatal health.   
 
2.2.3.2 Effects of Gestational Vitamin D Deficiency on Neonatal Health 
Size 
  The existing body of evidence indicates that low vitamin D levels during pregnancy are a 
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significant predictor for newborn size.  An American study found that serum 25(OH)D <37.5 
nmol/L was a significant risk factor for infants being born SGA (small for gestational age) 
among white, but not black, women (Bodnar, Catov et al. 2010).  A Dutch study of 3730 mothers 
found that infants born to mothers with serum 25(OH)D <29.9 nmol/L were more likely to be 
born SGA and had a significantly lower birth weight than those born to mothers with serum 
25(OH)D >50 nmol/L (Leffelaar, Vrijkotte et al. 2010).  An Iranian study of 449 pregnant 
women found that mothers who received the daily recommended doses of calcium and vitamin D 
had infants with higher birth length and were less likely to have infants with low birth weight 
(Sabour 2006).  Similarly, a US study including 2251 pregnant women found that vitamin D 
intake was a significant predictor for infant birth weight (Scholl and Chen 2009).  However, an 
Australian study found that first trimester vitamin D levels were not associated with birth weight, 
head circumference, knee-heel length, or crown-heel length (Morley, Carlin et al. 2006). 
  Randomized controlled trials (RCTs) of vitamin D supplementation have conflicting 
evidence on the role of vitamin D in infant size.  An RCT in 80 British mothers of Asian descent 
found that the incidence of SGA was higher in the placebo group than in mothers supplemented 
with 1000 IU of vitamin D per day (Brooke and Wood 1980; Brooke, Brown et al. 1981).  
Infants of the placebo group mothers subsequently gained less weight and had lower rates of 
linear growth than infants of the supplemented group (Brooke, Butters et al. 1981).  By contrast, 
a French RCT involving pregnant women in their third trimester gave one dose of 200,000 IU to 
one group (n = 27), 1000 IU daily to one group (n = 21), and a placebo to a third group (n = 29) 
and found no differences in birth weight between groups (Mallet, Gugi et al. 1986). 
  Studies based on dietary recall support the role of vitamin D in infant size.  A study 
performed in Calgary, Alberta showed that mothers who consumed more than one cup (>250 
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mL, n = 207) of milk per day during pregnancy had infants who weighed more than mothers who 
consumed less milk (n = 72).  Each additional cup of milk per day was associated with a 41g 
increase in birth weight.  Vitamin D was also a significant predictor of birth weight and each 
additional microgram of vitamin D per day was associated with an 11g increase in birth weight.  
However, there was no significant difference in infant lengths and head circumferences between 
groups (Mannion, Gray-Donald et al. 2006).   
  The Danish National Birth Cohort included data from 50,117 mother-infant pairs and 
found similar results.  Findings were adjusted for potential confounding variables and milk 
consumption was inversely associated with the risk of SGA birth and directly associated with 
large for gestational age (LGA) birth and birth weight. Milk consumption was also associated 
with very small increases in head circumference and birth length (Olsen, Halldorsson et al. 
2007).  Though this evidence is compelling, it is difficult to control for all confounding factors 
and larger, randomized-controlled trials are needed to assess the role of vitamin D in birth size. 
 
Apgar scores 
  Only one study investigated the relationship of maternal vitamin D with Apgar scores.  
This study assessed the vitamin D intake of 449 pregnant women in Iran and found that adequate 
maternal calcium and vitamin D intake was associated with higher 1-minute Apgar scores 
(Sabour 2006).  However, it did not measure serum levels of 25(OH)D, the effects of calcium 
and vitamin D were not assessed separately, and there was no adjustment for potential 
confounding factors.  Further research is required to support this finding. 
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Skeletal development 
Studies have associated maternal vitamin D status during pregnancy with bone 
development in utero and bone size during infancy and childhood.  One study involved 424 
pregnant women and used a high-resolution 3D ultrasound to measure fetal femur length and 
distal metaphyseal cross-sectional area.  This study found that lower maternal 25(OH)D 
concentrations were associated with greater femoral metaphyseal cross-sectional area and a 
higher femoral splaying index at 19 and 34 weeks’ gestation, which suggests that maternal 
vitamin D status can influence fetal bone development early in pregnancy (Mahon, Harvey et al. 
2010).  In another study, newborn tibial bone mineral content and cross-sectional area, but not 
bone mineral density, were higher in a group of newborns whose mothers had 25(OH)D 
concentrations >42.5 nmol/L compared with newborns whose mothers’ 25(OH)D concentrations 
were below this level, further suggesting the maternal vitamin D concentration influences bone 
size (Viljakainen, Saarnio et al. 2010).  When a subset of the participants in this study were 
followed at age 14 months, tibial cross-section area remained higher in children whose mothers 
had better vitamin D status during pregnancy (Viljakainen, Korhonen et al. 2011).  Finally, a 
study in the UK of 198 mother-child dyads found that maternal serum 25(OH)D deficiency or 
insufficiency was associated with reduced whole-body and lumbar spine bone mineral 
concentration in their 9-year-old children (Javaid, Crozier et al. 2006).  The universal conclusion 
of these studies is that vitamin D supplementation of pregnant women may lead to increased 
skeletal development and decreased fracture risk in their offspring. 
  Severe maternal vitamin D deficiency may result in congenital rickets and hypocalcemic 
seizures (Russell and Hill 1974; Orbak, Karacan et al. 2007), although this is rare.  
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2.2.3.3 Effects of Gestational Vitamin Deficiency on Infant and Child Health 
Neurological development 
  Low vitamin D levels during pregnancy may have long-lasting effects on the developing 
fetus.  The presence of vitamin D receptors throughout the brain and its role in the development 
of the nervous system implies that maternal vitamin D levels may have an impact on fetal brain 
maturation (Garcion, Wion-Barbot et al. 2002).  Only one study has assessed the role of vitamin 
D in the neurological development of the child.  A study performed in the UK (n = 178) reported 
that sufficient maternal serum 25(OH)D status (>75 nmol/L) did not appear to impact the 9-year-
old child’s psychological health or intelligence (Gale, Robinson et al. 2008).  However, no 
studies have investigated the relationship of maternal or newborn vitamin D status with 
neurological development in infancy. 
 
Asthma and atopy 
  Low dietary and supplemental intake of vitamin D during pregnancy has been associated 
with increased risk of wheezing illness, asthma and allergic rhinitis.  In Scotland, a study 
assessing the vitamin D intake of 1,212 mothers found that 5-year-old children were more likely 
to ever wheeze, wheeze in the previous year, or have a persistent wheeze if their mothers had a 
low vitamin D intake during pregnancy (Devereux, Litonjua et al. 2007).  A US study similarly 
found that 3-year-old children were more likely to have a recurrent wheeze if their mothers had a 
low vitamin D intake during pregnancy (Camargo, Rifas-Shiman et al. 2007).  In Finland, a 
study of 1669 5-year-old children found that the risk of asthma and allergic rhinitis was 
increased in children whose mothers had low vitamin D intake during pregnancy (Erkkola, Kaila 
et al. 2009), and in Japan, a study of 763 mother-child pairs found that low vitamin D intake 
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during pregnancy was a risk factor for eczema and wheeze in infants aged 16-24 months 
(Miyake, Sasaki et al. 2010). 
 
Diabetes 
  Maternal vitamin D deficiency has also been related to the risk of Type 1 and Type 2 
diabetes.  An Indian study of 568 mothers found that 5 and 9.5-year-old children of vitamin D-
deficient (<50 nmol/L) mothers had higher insulin resistance than children whose mothers had 
sufficient vitamin D levels during pregnancy (Krishnaveni, Veena et al. 2011).  A Norwegian 
survey of 85 diabetic patients and 1,071 control patients found that when mothers took cod liver 
oil during their pregnancy, their offspring had a lower risk of Type 1 diabetes (Stene, Ulriksen et 
al. 2000).   
 
2.2.4 Conclusion 
  Evidence suggests that low levels of vitamin D are extremely prevalent during pregnancy 
and may adversely affect neonatal, infant and child health.  In Saskatchewan, the prevalence of 
low levels of vitamin D is likely to be high due to the northern latitude of the province, the high 
Aboriginal population, the high prevalence of obesity, and the lack of sun exposure during the 
winter months.  Further studies will need to be conducted in order to estimate the prevalence of 
low levels of vitamin D in Saskatchewan’s pregnant population and appreciate the role of 
maternal vitamin D supplementation in infant and child health.   
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2.3 Vitamin D in Newborns 
2.3.1  Prevalence of Cord Blood Vitamin D Insufficiency and Deficiency 
  25(OH)D easily crosses the placenta (Hillman and Haddad 1974), and maternal levels of 
25(OH)D are slightly higher than cord blood 25(OH)D levels (Sachan 2005; Bodnar, Simhan et 
al. 2007).  Therefore, given the high prevalence of maternal vitamin D deficiency throughout the 
world, a similarly high prevalence of newborn vitamin D deficiency is expected.  Deficient cord 
blood vitamin D has been documented in India (n = 207, mean cord blood 21.0 +/- 14.2 nmol/L) 
(Sachan 2005), Iran (n = 552, 93% <35 nmol/L) (Maghbooli 2007), Australia (n = 901, 11% <25 
nmol/L) (Bowyer, Catling-Paull et al. 2009), Greece (n = 123, 8.1% <25 nmol/L) and the United 
States (n = 40, 65% <30nmol/L) (Lee, Smith et al. 2007), among other countries.  In an 
American study of 200 black and 200 white neonates, vitamin D deficiency (<37.5 nmol/L) and 
insufficiency (37.5-80 nmol/L) occurred in 45.6% and 46.8% of black neonates, respectively, 
compared with 9.7% and 56.4% of white neonates (Bodnar, Simhan et al. 2007).  Another study 
of 210 newborns performed in California found that 90% were either insufficient or deficient 
(<75 nmol/L) in vitamin D (Dror, King et al. 2011).  Even in lower latitudes and warm climates, 
vitamin D deficiency in newborns is extremely prevalent.  However, few studies have been 
performed in Canada. 
  Three Canadian studies have assessed cord blood vitamin D concentrations and had 
similar findings.  A Winnipeg study (n = 50) found that 36% of infants had deficient cord blood 
25(OH)D levels (<27.5 nmol/L).  Average cord blood 25(OH)D in the deficient group was 9.0 ± 
6.0 nmol/L, while average cord blood in the sufficient group was 39.7 ± 10.6 nmol/L (Weiler, 
Fitzpatrick-Wong et al. 2005).  In the Northwest Territories, a study of 121 newborns found that 
both native and non-native newborns were on average deficient (34.2+/-13.1 nmol/L and 41.4+/-
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23.5 nmol/L, respectively) (Waiters, Godel et al. 1999).  In Newfoundland, a study of 51 
newborns showed that average cord blood vitamin D was 48.6 nmol/L ± 17.5 nmol/L in the 
winter and 63.3 nmol/L ± 13.5 nmol/L in the summer.  Approximately 49% of infants were 
insufficient and 35% were deficient (Newhook, Sloka et al. 2009).  No studies have assessed 
cord blood vitamin D status in Saskatchewan. 
 
2.3.2  Outcomes of Cord Blood Vitamin D Sufficiency, Insufficiency and Deficiency 
  Although many studies have commented on the prevalence of low cord blood vitamin D 
levels, few have studied its relationship with infant health.  The following studies represent the 
majority of the literature available on the association of cord blood vitamin D status with infant 
and child health outcomes. 
Neonatal heart failure and symptomatic neonatal hypocalcemia 
  Similar to the case reports of maternal vitamin D deficiency in relation to neonatal rickets 
and hypocalcemia (Russell and Hill 1974; Orbak, Karacan et al. 2007), case reports have 
associated low serum 25(OH)D in newborns with neonatal heart failure (Maiya, Sullivan et al. 
2008) and symptomatic neonatal hypocalcemia (Shenoy, Swift et al. 2005; Teaema and Al 
Ansari 2010).  In Qatar, 19 cases of neonatal hypocalcemia due to neonatal serum vitamin D 
deficiency were ultimately attributed to maternal vitamin D deficiency (Teaema and Al Ansari 
2010).  Similarly, in England, a review of 16 infants with rickets-associated dilated 
cardiomyopathy found that no infant or mother was receiving the recommended vitamin D 
supplementation (Maiya, Sullivan et al. 2008), suggesting that these life-threatening 
presentations of heart failure could have been prevented.    
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Infection 
Two studies have associated low cord blood vitamin D levels with an increased risk of 
infections.  Low cord blood vitamin D has been associated with an increased risk of RSV 
(respiratory syncytial virus) in the first year of life (Belderbos 2011) and an increased risk of 
respiratory infections (Camargo, Ingham et al. 2011).  The increased infection rate could be 
explained by the role of vitamin D in immunity, as one study demonstrated that low cord blood 
vitamin D decreased in vitro monocyte responses (Walker, Zhang et al. 2011), and another found 
that high cord blood vitamin D levels were associated with lower numbers of T regulatory cells 
(Chi, Wildfire et al. 2011). (For more information on the role of vitamin D in the immune 
system, please see Section 2.4.2).  These studies suggest that vitamin D status in utero may 
influence immune function in infancy.  Additional studies are required to determine the role of 
vitamin D in neonatal health and particularly in the risk of infection. 
 
Asthma and atopy 
  Evidence surrounding the role of neonatal vitamin D levels in asthma and allergy is 
conflicting.  One study found that both high and low levels of cord blood 25(OH)D were 
associated with increased isoallergen sensitization, but that vitamin D levels were not associated 
with asthma or allergic rhinitis (Rothers, Wright et al. 2011).  Similarly, another study found that 
low cord blood 25(OH)D was associated with increased risk of respiratory infections and 
wheezing, but not with an increased risk of asthma (Camargo, Ingham et al. 2011).  In one study 
(n = 649), cord blood vitamin D deficiency (< 27 nmol/L) was not associated with food 
sensitivity (Liu, Wang et al. 2011).  However, vitamin D deficiency did increase the risk of food 
sensitivity among children carrying single nucleotide polymorphisms (SNPs) in the genes 
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involved in regulating IgE and 25(OH)D concentrations (Liu, Wang et al. 2011).  This gene-
vitamin D interaction is likely not unique to food sensitivity and probably exists with many other 
conditions.  Future studies should search for associations between health outcomes and genetic 
mutations, as relationships that are not initially apparent may surface once genetic variation is 
accounted for. 
  The mechanism underlying these observations may pertain to vitamin D’s role as an 
immunomodulator.  One study found that vitamin D supplementation in mothers resulted in the 
induction of tolerogenic dendritic cells in cord blood, which suggests that vitamin D status in 
utero may influence the development of atopic diseases later in life (Rochat, Ege et al. 2010). 
Another found that cord blood vitamin D levels were correlated with interleukin-10 (IL-10) 
levels, and that IL-10 levels were highest in the summer (Zittermann 2004).  Because IL-10 is 
also involved in tolerizing exogenous antigens, it may also predispose infants to increased atopic 
risk.  Research is necessary to further characterize the role of vitamin D in atopy. 
 
Other health outcomes 
  One small Canadian study (n = 50) reported that low cord blood 25(OH)D concentration 
was related to lower bone mineral content in newborns (Weiler, Fitzpatrick-Wong et al. 2005).  It 
also found that low vitamin D concentrations were associated with greater infant weight and 
length.  This particular finding contradicts the general consensus of existing research, which has 
associated lower gestational vitamin D levels with smaller infant size (see Section 2.2.3.2). 
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2.3.3 Conclusion 
  Several studies have indicated a high prevalence of low vitamin D levels in newborns 
globally.  In Canada, low levels of cord blood vitamin D were demonstrated in Newfoundland, 
the Northwest Territories, and Winnipeg.  As previously mentioned, Saskatchewan’s many risk 
factors for vitamin D deficiency put its newborns at high risk for having low levels of vitamin D.  
An estimate of the prevalence of vitamin D deficiency in Saskatchewan’s newborns would 
establish the relevance of this problem to our province, while the identification of risk factors 
may indicate populations that require screening and primary prevention strategies.  Finally, 
research that identifies the neonatal outcomes of vitamin D deficiency may aid in clarifying the 
role of vitamin D in physiology and consequently reinforce the importance of vitamin D 
supplementation. 
 
2.4 Vitamin D in Children 
2.4.1 Prevalence of Vitamin D Insufficiency and Deficiency in Children 
  It is conceivable, though not proven, that those born with a low level of vitamin D may 
continue to have a low level of vitamin D later in life.  As well, it may not be uncommon for a 
child to develop vitamin D deficiency or insufficiency during childhood.  A solid understanding 
of the risk factors for vitamin D deficiency may improve health behaviours of families during 
pregnancy, infancy and childhood and prevent vitamin D deficiency at all stages of life.  As well, 
an understanding of the physiologic mechanisms of vitamin D in utero and infancy are the first 
steps to understanding the physiology of vitamin D in later life.  Intrauterine vitamin D 
deficiency may predispose to chronic diseases which effect individuals at all ages.  It is 
imperative to make connections between studies performed during pregnancy, infancy, 
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childhood, adolescence, adulthood and old age to fully understand how vitamin D levels may 
impact an individual’s future health. 
  A study analyzing the results of the 2007/2008 Canadian Health Measures survey 
indicated that for Canadians aged 6–11 years, only 52% have vitamin D levels in the sufficient 
range (>75 nmol/L), while only 35% of children aged 12-19 years have vitamin D levels in the 
sufficient range (Langlois, Greene-Finestone et al. 2010).  The prevalence of vitamin D 
deficiency in young children is high in many countries, including England (Callaghan, Moy et al. 
2006), Greece (Nicolaidou, Hatzistamatiou et al. 2006), Iran (Neyestani, Hajifaraji et al. 2012), 
India (Babu and Calvo 2010), Qatar (Bener, Al-Ali et al. 2009) and the United States (Gordon, 
DePeter et al. 2004; Gordon, Feldman et al. 2008; Cole, Grant et al. 2010; Merewood, Mehta et 
al. 2010).  Several Canadian studies also indicate a high prevalence of low vitamin D levels in 
children.  In Manitoba, a cross-sectional study of 80 mother-infant pairs showed that 43% of 
infants 3-24 months had a 25(OH)D level below normal (Lebrun, Moffatt et al. 1993).  In 
Quebec, a study of 1753 school-aged children showed that more than 93% had 25(OH)D levels 
below 75 nmol/L, and mean levels ranged from 40 to 50 nmol/L (Mark, Gray-Donald et al. 
2008).  Another Quebec study of 159 children aged 8-11 whose parents were obese or had 
metabolic syndrome showed that over 90% of them had serum 25(OH)D levels in the deficiency 
range (Mark 2010).  In Edmonton, the mean serum 25(OH)D level of 68 pediatric patients 
presenting to the emergency room was 47 nmol/L, and all but one of the participants had a 
vitamin D concentration <80 nmol/L (Roth, Martz et al. 2005).  Finally, data collected from our 
research group in Saskatoon indicated a mean vitamin D level of 49 +/- 24 nmol/L among a 
group of children admitted to the pediatric intensive care unit with acute lower respiratory 
infection (McNally, Leis et al. 2009).   
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  The high prevalence of low vitamin D levels among Canadian mothers and children can 
be explained by the reduced skin synthesis of vitamin D during the winter as well as an 
inadequate intake of vitamin D in the diet.  A study which analyzed the results of the 2004 
Canadian Community Health Survey Cycle 2.2 showed that the majority of Canadians consume 
less than the recommended intake of vitamin D from food, suggesting that more vitamin D 
should be added to fortified foods, and that a wider range of foods should be fortified 
(Vatanparast, Calvo et al. 2010).  It also showed that white Canadians had a higher vitamin D 
intake than non-white Canadians in most age sex groups (Vatanparast, Calvo et al. 2010), which, 
along with darker skin tone and genetic diversity, aids in explaining the discrepancy in vitamin D 
levels observed between white and non-white ethnicities.  Given that the same risk factors may 
create low levels of vitamin D in utero as in infancy and childhood, early detection and 
prevention of low levels of vitamin D in pregnancy may substantially improve long-term child 
health. 
 
2.4.2 Outcomes of Childhood Vitamin D Insufficiency and Deficiency 
Rickets 
  Severe vitamin D deficiency, which causes rickets, has been well-known and documented 
since the 1800s (Welch, Bergstrom et al. 2000).   However, despite the relatively recent 
fortification of foods with vitamin D, nutritional rickets appears to be re-emerging in developed 
countries (Welch, Bergstrom et al. 2000; Allgrove 2004).  In Canada, a survey of 2325 
pediatricians over two years estimated the incidence of rickets in Canada to be 2.9 per 100,000 
(Ward, Gaboury et al. 2007).  Of the 104 cases identified by the survey, the mean age at 
diagnosis was 1.4 years, 89% had darker skin tones, and 94% had been breast fed.  None of the 
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breast-fed infants had been supplemented according to current guidelines (400 IU/day) (Ward, 
Gaboury et al. 2007), highlighting the importance of supplementing darker-skinned infants 
during the first year of life.  In a Winnipeg hospital between 1972-1984, 48 cases of rickets were 
identified (Haworth and Dilling 1986) and in a Toronto hospital between 1988 and 1993, 17 
cases of rickets were identified (Binet and Kooh 1996).  Given the high prevalence of vitamin D 
insufficiency and deficiency among Canadian children, clinically apparent cases of deficiency 
represent only a small fraction of vitamin D-related child health outcomes. 
 
Infections and Immunity 
  Vitamin D is able to act in an autocrine or paracrine manner in regulating immune 
function (Aranow 2011).  The vitamin D receptor is expressed on B cells, T cells, and antigen-
presenting cells, and these cells are also capable of producing 1-alpha hydroxylase, the enzyme 
responsible for converting 25(OH)D to the active form of vitamin D, 1,25(OH)2D.  The 
metabolism of vitamin D is also regulated locally by the immune environment, resulting in local 
levels different from systemic levels.  The macrophage 1-alpha hydroxylase is not PTH-
dependant (Wu, Ren et al. 2007) and instead responds to circulating levels of 25(OH)D, 
interferon (IFN) gamma, interleukin (IL) 1, or tumor necrosis factor (TNF) alpha (van Etten, 
Stoffels et al. 2008).  The macrophage 24-hydroxylase is non-functional, so there is no negative 
feedback of 1,25(OH)2D production (Aranow 2011).  The significance of vitamin D as an 
autocrine hormone continues to be investigated. 
  Vitamin D is an important factor influencing inflammatory responses (Abu-Amer 1993; 
Wang, Nestel et al. 2004).  Vitamin D dampens systemic inflammatory response by inhibiting 
antigen-induced T-cell proliferation, antagonizing the pro-inflammatory Th1 response, 
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suppressing macrophage release of pro-inflammatory cytokines, altering gene expression, and 
decreasing adherence and chemotaxis of neutrophils (Bhalla, Amento et al. 1984; Rigby, 
Denome et al. 1987).  These roles are pertinent to inflammatory responses common to many 
diseases.   
  Vitamin D status has been associated with infection risk.  In 1981, Hope-Simpson 
published a study that recognized the increased incidence of influenza A during the winter in 
both northern and southern latitudes, while equatorial countries had a steady incidence of 
influenza A (Hope-Simpson 1981).  Since then, many studies have demonstrated a direct 
association between hypovitaminosis D and increased risk of infection (McNally, Leis et al. 
2009; Hewison 2010; Walker, Zhang et al. 2011).  One study examined data from 18,883 
individuals over age 12 in the US and found an association between low vitamin D levels (<30 
ng/mL) and upper respiratory tract infection (Ginde, Mansbach et al. 2009).  Low vitamin D 
levels have also been associated with increased risk of bacterial vaginosis (Bodnar, Krohn et al. 
2009), influenza (Cannell, Vieth et al. 2006), and HIV (Villamor 2006).  Most convincingly, a 
randomized, double-blind, placebo-controlled trial involving 167 schoolchildren showed that 
vitamin D supplementation reduced influenza A incidence by 42% (Urashima, Segawa et al. 
2010). 
  In children, many studies have associated low vitamin D levels with an increased risk of 
respiratory infections (Muhe 1997; McNally, Leis et al. 2009).  In an Ethiopian study of 500 
children with pneumonia and 500 controls, children with pneumonia were 13 times more likely 
to have rickets, suggesting that low levels of vitamin D may predispose children to respiratory 
infection (Muhe 1997).  An Indian study of 80 cases of acute lower respiratory infection (ALRI) 
and 70 controls aged 2-60 months found that children with vitamin D levels >22.5 nmol/L had a 
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decreased risk of ALRI (Wayse, Yousafzai et al. 2004).  A study conducted by our research 
group in Saskatoon found no difference in vitamin D levels between children diagnosed with 
pneumonia or bronchiolitis (n = 105) and children with no respiratory symptoms (n = 92).  
However, children admitted to the pediatric intensive care unit with ALRI were more likely to be 
vitamin D deficient than their healthy counterparts (McNally, Leis et al. 2009).  However, no 
studies have investigated the relationship of cord blood vitamin D status with the risk of 
infection or illness at birth. 
 
Autoimmune disease and diabetes 
  Low 25(OH)D levels have been associated with increased risk of autoimmune diseases, 
such as multiple sclerosis (McMichael and Hall 1997; Munger, Zhang et al. 2004; Willer, 
Dyment et al. 2005), type 1 diabetes mellitus (Staples, Ponsonby et al. 2003; Willer, Dyment et 
al. 2005; Svoren, Volkening et al. 2009), rheumatoid arthritis (Merlino, Curtis et al. 2004), lupus 
(Kamen and Aranow 2008), and inflammatory bowel disease (Cantorna, Munsick et al. 2000). 
Northern latitude is associated with an increased risk of these diseases, further implicating 
vitamin D in their pathogenesis (Holick 2007).  In fact, the risk of multiple sclerosis is decreased 
by approximately 50% in those living below 35 degrees latitude for the first 10 years of life 
(Ponsonby, McMichael et al. 2002; Van Amerongen, Dijkstra et al. 2004).  However, a Finnish 
study had an opposite finding; vitamin D supplementation during the first year of life was 
associated with an increased risk of asthma, atopy and allergic rhinitis at age 31 years 
(Hypponen, Sovio et al. 2004).  Despite the conflicting findings of present research, existing 
studies suggest that vitamin D supplementation during infancy may have long-lasting impacts on 
future health. 
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  Several studies have associated childhood vitamin D levels with the risk of developing 
Type 1 diabetes.  A systemic review and meta-analysis of five studies found that the risk of type 
1 diabetes was reduced in infants who were supplemented with vitamin D in all studies (Zipitis 
2008).  The odds ratio for the risk of diabetes in those supplemented compared with those not 
supplemented was  0.71 (95% CI 0.60 to 0.84), and there was evidence for a dose-response effect 
with supplementation (Zipitis 2008).  
  Studies also support the role of vitamin D in the pathogenesis of diabetes.  Vitamin D 
receptors have been found in both beta islet cells and immune cells, and a protective effect of 
vitamin D in cytokine-induced beta cell dysfunction has been demonstrated (Mathieu, Gysemans 
et al. 2005).  Another study found that vitamin D deficiency was associated with increased 
insulin resistance and metabolic syndrome (Chiu, Chu et al. 2004).  Finally, low vitamin D status 
has also been associated with increased fasting blood glucose and other indicators of lipid 
metabolism in Canadian children, which suggests a role for vitamin D in cardiovascular health as 
well as diabetes (Delvin, Lambert et al. 2010). 
 
Cancer 
  In adults, serum 25(OH)D levels have been associated with increased risk of many types 
of cancer, including colorectal (Lappe, Travers-Gustafson et al. 2007), breast (Garland, Garland 
et al. 1990; Grant 2002), prostate (Bodiwala, Luscombe et al. 2003; Tuohimaa, Tenkanen et al. 
2004), and colon cancer (Garland, Comstock et al. 1989; Pritchard, Baron et al. 1996).  People 
living at high latitudes are also at increased risk for these and other cancers (Holick 2007). A 
randomized controlled trial involving 1179 postmenopausal women found that vitamin D 
supplementation reduced the risk of cancer by 60 to 77% (Lappe, Travers-Gustafson et al. 2007), 
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and there is a growing consensus that vitamin D supplementation may reduce the risk of cancer 
in all age groups.  
  Fewer studies have been conducted in the pediatric population.  In children and young 
adults, sunlight exposure reduces the risk of non-Hodgkin’s lymphoma by 40% (Chang, Smedby 
et al. 2005), and decreases the risk of death from malignant melanoma once it develops 
(Berwick, Armstrong et al. 2005).  Lab studies show that vitamin D concentrations >75 nmol/L 
maintain normal cell growth and prevent cells from undergoing malignant transformation 
(Mawer, Hayes et al. 1994; Cross, Bareis et al. 2001; Tangpricha, Flanagan et al. 2001).  Its role 
in cellular differentiation, apoptosis, proliferation and angiogenesis (Nagpal, Na et al. 2005) 
makes vitamin D a promising target for cancer research and increases the importance of vitamin 
D supplementation in protecting future health. 
 
Cardiovascular Disease 
  Vitamin D’s role in cardiovascular health is also being investigated (Wang, Pencina et al. 
2008).  As previously mentioned, low vitamin D levels have been associated with increased 
fasting blood glucose and other indicators of lipid metabolism in Canadian children, an 
observation that could have implications for future cardiovascular disease (Delvin, Lambert et al. 
2010).  Another study reported that deficient levels of vitamin D may predispose children to 
obesity (Gilbert-Diamond 2010).  Other studies show that higher latitude increases the risk of 
hypertension and cardiovascular disease (Rostand 1997; Zittermann 2006), and that low vitamin 
D levels are associated with congestive heart failure in adults (Zittermann 2006).  Interestingly, 
hypertensive patients who were exposed to ultraviolet light were able to normalize their blood 
pressure (Krause, Buhring et al. 1998), which suggests a role for vitamin D influencing 
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cardiovascular health. Further studies are warranted to investigate the role of vitamin D in 
cardiovascular health. 
 
Neurological Development and Mental Health 
  Many studies have documented the presence of vitamin D, its receptor and its metabolites 
in the brain and recognized  that vitamin D may be an important modulator of brain development 
(Eyles, Smith et al. 2005; Eyles, Feron et al. 2009; Eyles, Burne et al. 2011; Harms, Burne et al. 
2011).  Vitamin D may affect the developing brain through its roles in cellular differentiation, 
neurotransmitter synthesis, neurotrophic factor expression, and the expression of proteins 
involved in neuronal cell structure and metabolism (Eyles, Burne et al. 2011).  VDR-deficient 
mice exhibit neurobehavioural abnormalities, including increased anxiety, reduced social 
behavior, abnormal grooming, pup cannibalism, impaired nest building, and neophobia (Kalueff, 
Keisala et al. 2006).  They also exhibit increased susceptibility to epilepsy and impaired 
vestibular function (Kalueff, Minasyan et al. 2006; Keisala, Minasyan et al. 2009).  These 
findings suggest that vitamin D is necessary for normal neurological development and that low 
levels of vitamin D may result in neurological impairment. However, as previously mentioned, 
only one study has investigated the role of maternal vitamin D deficiency on child psychological 
health, and it found no association between maternal vitamin D level and child psychological 
health or intelligence at 9 years of age (Gale, Robinson et al. 2008). 
  Insufficient or deficient Vitamin D status during infancy and childhood may predispose 
individuals to an increased risk of mental health diseases.  Vitamin D levels have been associated 
with seasonal affective disorder (Gloth, Alam et al. 1999), and sufficient levels of vitamin D 
during the first year of life have been associated with a decreased risk of schizophrenia in males 
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(McGrath, Saari et al. 2004).  Low vitamin D levels are occasionally responsible for neonatal 
hypocalcemic seizures (Camadoo, Tibbott et al. 2007), and researchers are investigating a 
possible role for vitamin D in epilepsy (Janjoppi, Katayama et al. 2008).  Low levels of vitamin 
D are frequently found in patients with minor and major depression (Hoogendijk, Lips et al. 
2008; Arvold, Odean et al. 2009), and supplemental vitamin D and light therapy reduce 
depressive symptoms (Jorde, Sneve et al. 2008; Shirani and St Louis 2009).  It is likely that 
vitamin D status plays a role in the pathogenesis of many types of mental illness and that 
supplementation during pregnancy and infancy may improve outcomes in depression and other 
disorders.  
  
2.4.3 Conclusion 
  Vitamin D deficiency and insufficiency is prevalent in Canadian children, and the myriad 
outcomes associated with vitamin D deficiency can adversely affect long term health. While 
many of these studies are observational and only associations have been made, randomized-
controlled trials are unlikely to occur due to the health detriment to any group assigned to a 
placebo arm.  Vitamin D deficiency is associated with many adverse outcomes during infancy, 
childhood, adolescence and adulthood.  Further research is necessary to ascertain vitamin D’s 
role in the pathogenesis of these diseases.  It is possible that fetal and infant vitamin D levels 
may have more long-lasting effects on child and adult health than previously imagined. 
 
2.5 Health and Economic Burdens of Vitamin D Deficiency 
  Given the substantial evidence for an association between vitamin D levels and health 
status, including potential life-threatening associations, one study estimated that the Canadian 
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death rate could fall by 37,000 deaths (22,300-52,300 deaths) if the mean serum 25(OH)D level 
of Canadians was increased to 105 nmol/L.  This represents 16.1% of annual deaths and could 
reduce the annual economic burden by approximately $14.4 billion (6.9%) (Grant, 
Schwalfenberg et al. 2010).  In Saskatchewan, the health and economic burdens of low vitamin 
D levels are likely to be higher than the national average because of the northern latitude in 
which much of the province’s population resides, the inadequate winter sun exposure and 
reduced UVB radiation from winter sunlight strength, the high prevalence of obesity, the high 
Aboriginal population and the divergence of the Aboriginal population from their traditional 
fish-based diet.  Saskatchewan’s pregnant mothers, and therefore their newborns, are likely to 
exhibit a high prevalence of vitamin D insufficiency and deficiency.  If low vitamin D levels 
occur during a critical period in fetal development, it is possible that the fetus may experience 
long term adverse health consequences that would have been preventable through adequate 
maternal supplementation. 
 
2.6 Conclusions From the Literature Review and Rationale for the Current Study   
  The role of vitamin D in the pathogenesis of many non-skeletal infant and child health 
outcomes is only beginning to be elucidated.  Studies are difficult to interpret because of 
differences in the definitions of vitamin D insufficiency and deficiency.  Furthermore, the 
acceptable level of vitamin D for neonates, infants and children is still debated.  Vitamin D 
studies in newborns are few and far between despite the inherent vulnerability of the fetus in 
utero. 
  Canada’s, and particularly Saskatchewan’s, populations are at high risk of being vitamin 
D deficient due to their high Aboriginal populations, northern latitude, and limited sun intensity 
40 
 
and exposure during the winter.  Results of Canadian and non-Canadian studies indicating the 
prevalence of maternal vitamin D deficiency during pregnancy are alarming.  Given that vitamin 
D travels through the placenta, a similarly prevalent level of newborn vitamin D deficiency 
would be expected.  However, no studies have examined vitamin D levels of Saskatchewan’s 
newborn population.   
  Both low maternal and cord blood vitamin D levels have been linked with adverse 
outcomes in infancy and childhood.  Maternal vitamin D levels have been linked with infant size 
and Apgar scores, and low levels of vitamin D during pregnancy may increase a child’s risk of 
wheezing, asthma, and type 1 diabetes.  Cord blood vitamin D levels have been associated with 
neonatal heart failure and hypocalcemia, increased risk of childhood infections, and increased 
risk of atopic disease.  Maternal supplementation of vitamin D may mitigate the risk of several 
infant and childhood diseases.  Therefore, research indicates that the intrauterine environment 
may have a long-lasting impact on the fetus and eventually the individual.  However, clinical 
associations have not been adequately explored in newborns, and the pathophysiology of the 
associations identified in children remains unknown. 
  Although many studies have demonstrated that cord blood vitamin D deficiency and 
insufficiency is prevalent, it remains uncertain what constitutes “low” levels of vitamin D for 
newborns because correlations between low vitamin D levels and clinical outcomes are lacking.  
It is unclear whether socio-demographic, obstetric or personal health factors may influence 
newborn vitamin D levels, and it is unknown whether low cord blood vitamin D levels are 
associated with adverse clinical outcomes at birth.  Finally, there are few Canadian studies and 
no Saskatchewan studies that describe cord blood vitamin D levels.    
  This research aims to estimate the prevalence of low levels of vitamin D among 
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Saskatoon’s newborns, which may aid in establishing the extent of vitamin D deficiency and 
insufficiency in this population.  This research also aims to identify socio-demographic, obstetric 
and personal health factors that may influence cord blood levels of vitamin D, and identify 
whether adverse clinical outcomes may be associated with low vitamin D levels. 
  The association of newborn vitamin D status with neonatal outcomes will aid the 
understanding of the role of vitamin D’s role in utero and its impact on a newborn’s health.  
Clinical associations may also aid in the development of age-specific reference ranges for 
vitamin D levels, as “low” vitamin D levels for adults may be normal in newborns and may not 
result in any adverse clinical outcomes. 
 Finally, despite compelling evidence of the importance of vitamin D sufficiency during 
pregnancy, there is no consensus on guidelines for supplementation.  The prevalence of vitamin 
D deficiency and insufficiency in newborns and any adverse outcomes to the fetus or child may 
be decreased or prevented with adequate maternal vitamin D supplementation.  The final goal of 
this research is to educate ourselves and our communities about the importance of vitamin D 
supplementation.  This knowledge will empower pregnant mothers, families and communities to 
make informed decisions about the benefits of vitamin D supplementation.  We hope to promote 
adequate vitamin D supplementation throughout all stages of life. 
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CHAPTER 3: NEWBORN VITAMIN D STUDY 
3.1 MATERIALS AND METHODS 
3.1.1 Study design 
  This study had a cross-sectional  design.  Participants were recruited between December, 
2011 and February, 2012.  The study was advertised through posters in Royal University 
Hospital (RUH), presentations at prenatal classes, and brochures available through midwives and 
the West Winds Primary Health Centre.  
  Some participants were recruited at prenatal classes and informed consent was obtained 
after the class.  Most participants were approached on the Assessment, Antepartum and Labour 
and Delivery wards at RUH.  Participants were approached by the researcher when nurses 
deemed they were appropriate candidates for the study and depending on the researcher’s 
availability.  Nurses of potential participants were always approached prior to entering any room 
to ensure that potential participants were eligible for the study and comfortable enough to give 
informed consent.  The study was explained to potential participants and their families and they 
were given approximately half an hour to consider participating.   
  After consent was obtained, participants were asked to fill out a questionnaire containing 
questions about the mother’s health and demographic information.  At delivery, nurses collected 
a cord blood sample for vitamin D measurement and this was stored in a refrigerator until 
transport to the research laboratory.  After delivery, a spectrophotometer was used to measure the 
skin reflectance of the infant.  The medical records pertaining to labour, birth and immediate 
post-partum history for the mother and the infant were used to collect information pertaining to 
the pregnancy and delivery as well as anthropometric measurements and health status of the baby 
at birth. This information was entered into an electronic database. (See Appendix 1 for Consent 
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Form, Participant Questionnaire and Recruitment Materials.) 
 
3.1.2 Subjects 
  The study population included 65 maternal-fetal dyads delivering in the Saskatoon Health 
Region (latitude 52°N).  Consenting mothers of singleton pregnancies delivering in the 
Saskatoon Health Region were included.  Any pregnant women with pre-existing parathyroid or 
calcium conditions, those who took medications that interfere with calcium metabolism (such as 
diuretics or calcium channel blockers), those with thyroid disease and those without informed 
consent were excluded. 
  Of the 89 participants recruited for the study, proper informed consent was not assured 
for five participants and their information was not used in the analysis.  Of the 84 participants 
enrolled in the study, 19 failed to undergo cord blood collection at delivery and although their 
demographic information was collected the variable of interest (cord blood vitamin D level) was 
not available and therefore the information from these participants was excluded from statistical 
analysis.  As well, these participants were not followed post-partum, and therefore no 
information about the obstetric or neonatal outcomes of these participants is available.  For two 
of these cases, samples were not collected due to precipitous deliveries.  For the remaining 17 
cases, the reason for failed blood collection was unknown but was likely due to a failure to 
communicate participatory status with nurses.  The remaining 65 samples were included in the 
statistical analysis. 
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3.1.3 Data Collection 
3.1.3.1 Cord Blood Collection, Storage and Analysis 
  At the time of delivery, cord blood (3cc) was collected by needle/syringe withdrawal 
from an umbilical cord vein into a 3cc capacity heparinized vacutainer.  Samples were stored in a 
refrigerator (4oC) until they were transported to the testing laboratory.  There, they were 
centrifuged at 2500 revolutions per minute for 10 minutes, the supernatant was removed, and the 
supernatant was stored at -80°C until analysis.  
  Quantitative plasma 25(OH)D was determined by enzyme immunoassay 
(Immunodiagnostic Systems Ltd.).  The assays were performed by the study investigators in the 
Pediatric Rheumatic Disease Research Laboratory, University of Saskatchewan as we have 
previously described (McNally, Matheson et al. 2008; McNally, Matheson et al. 2008) and were 
run in accordance with the manufacturer’s specifications. Vitamin D External Quality 
Assessment Scheme (DEQAS; www.deqas.org) samples were run in parallel with subject 
samples.   
 
3.1.3.2 Socio-Demographic, Obstetric and Personal Health Information 
  At enrolment, a study number was assigned to each participant and the following 
enrolment information documented (See Appendix 1 for Study Questionnaire):  
• Date of enrolment 
• Maternal age 
• Marital status: married, single, divorced, separated, common-law, widowed (Statistics 
Canada 2006).  Due to the small number of participants in other categories, marital status 
was dichotomized into married and common-law for the purposes of analysis 
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• Maternal area of residence: determined by forward sortation area (the first three 
characters of postal code; as an approximate indicator of rural residence a ‘zero’ as the 
second character was considered rural and any other number as the second character as 
urban) (Statistics Canada 2008) 
• Maternal education level: elementary, high school, some university, technical training 
beyond high school, one or more university degrees, other (Statistics Canada 2006).  For 
analysis purposes the education level was dichotomized as elementary or high school 
education and some post-secondary education 
• Household income: <$10,000, $10,000 – $25,000, $25,001 – $50,000, $50,001 – 
$100,000, >$100,000.  Due to the small number of participants in other categories, these 
five categories were truncated into three categories (<$50,000, $50,001 - $100,000, and 
>$100,000) for the purposes of analysis 
• Parity: number of previous births trichotomized into no previous births, 1 previous birth 
and greater than 1 previous birth 
• Self-reported pre-pregnancy height (cm) and weight (kg) 
• Maternal vitamin D supplementation: amount, frequency, duration.  Dichotomized as 
yes/no, where ‘yes’ indicated some vitamin D supplementation other than a prenatal 
supplement 
• Infant ethnicity: referred to all ethnic origins of the fetus.  Non-white ethnicities included 
East and Southeast Asian, Aboriginal, Chinese, South Asian, American Indian, East 
Indian, Caribbean or Arab origins (Statistics Canada 2006).  For analysis purposes 
ethnicity was dichotomized into Caucasian origins only and some non-Caucasian 
ethnicity 
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• Maternal occupation: Management Occupations, Business, Finance and Administrative 
Occupations, Natural and Applied Sciences and Related Occupations, Health 
Occupations, Occupations in Social Science, Education, Government Service and 
Religion, Occupations in Art, Culture, Recreation and Sport, Sales and Service 
Occupations, Trades, Transport and Equipment Operators and Related Occupations, 
Occupations Unique to Primary Industry, Occupations Unique to Processing, 
Manufacturing and Utilities, Student, Other (list) (Statistics Canada 2006).  Mother’s 
occupation was not used during statistical analysis as many participants answered 
“Other.” As well, it was not clear if the participant had previously worked or was 
currently working outside the home 
• Pre-pregnancy medical conditions: listed.  Dichotomized as yes/no (has medical 
diagnosis for which medication is taken and no medical conditions) 
• Infections or illnesses during the pregnancy.  Dichotomized as yes/no 
• Pre-pregnancy weight was confirmed using pre-pregnancy or early pregnancy weight in 
the medical chart.  Pre-pregnancy height and weight were used to calculate pre-
pregnancy BMI (kg/m2)  
 
  All information was entered into an electronic database under the study number of the 
participant. 
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3.1.3.3   Anthropometric, Pregnancy and Delivery-Related Information 
  After delivery, health records pertaining to the pregnancy and delivery were consulted to 
obtain the following information:   
• Maternal weight gain during pregnancy: kg (determined by subtracting weight at first 
prenatal visit from current weight or weight at last prenatal visit) 
• Gestational age: weeks 
• Method of delivery (vaginal or Cesarean birth) 
• Presence of complications with delivery.  Dichotomized as no complications or any 
complications during delivery; any complications were specified as a string variable and 
included, as examples, fetal decelerations, shoulder dystocia, vacuum or forceps-assisted 
delivery, and Cesarean section for non-reassuring fetal heart rate, failure to progress, or 
malpresentation,   
• Infant height (cm), weight (g), head circumference (cm) 
• Apgar scores: a measurement of neonatal vitality, measured at 1, 5 and 10 minutes.  
Apgar scores are very infrequently measured at 10 minutes and 91% of this data was 
missing.  Therefore only Apgar scores at 1 and 5 minutes were included in the analysis 
• Presence of any illness in the newborn.  Dichotomized as yes/no, where ‘no’ indicated no 
illness and ‘yes’ indicated any neonate who was admitted to the neonatal intensive care 
unit or required any assisted ventilation or medical intervention immediately after birth 
 
  This information was entered into an electronic database under the study number of the 
participant. 
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3.1.3.4   Skin Tone 
  Skin pigmentation was estimated by measuring skin reflectance using a portable 
spectrophotometer (Model cm-600d, Konica Minolta).  Skin reflectance readings (L*) were 
taken at the inner aspect of the middle right forearm as well as on the sternum.  L* is an index of 
reflectance ranging from 0 (perfect black) to 100 (perfect white). 
 
3.1.4   Statistical Analysis 
  All statistical tests were performed using SPSS Statistics 19 software.  The definitions of 
vitamin D deficiency, insufficiency and sufficiency are as follows: vitamin D sufficiency (> 75 
nmol/L), vitamin D insufficiency (50 to 74.99 nmol/L) and vitamin D deficiency (< 50 nmol/L) 
(Holick, Binkley et al. 2011).   
 
3.1.4.1 Description of Study Population and Vitamin D Status 
   Descriptive demographic data were used to provide information about the population 
under investigation.  A comparison between the 65 included and 19 excluded participants was 
performed using chi-square tests for categorical variables with only two categories and t tests 
were used for continuous variables.   
 A histogram and tests for skewness and kurtosis were used to determine whether the cord 
blood vitamin D level had a normal distribution (see Figure 1 in Section 3.2.1).  Once the 
assumption of normality was satisfied, further statistical analysis using cord blood vitamin D 
level as a continuous dependent variable could be pursued. 
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 3.1.4.2 Risk Factors for Low Cord Blood Vitamin D Levels 
  Mean levels of vitamin D were reported for each category within each categorical 
variable.  Independent t-tests and one-way ANOVAs were used to determine whether any 
statistically significant difference existed between the mean vitamin D levels between categories 
for each categorical variable. The Pearson correlation coefficient was used to evaluate the 
correlation between continuous variables and vitamin D levels.  
  Linear regression was used to determine whether any association existed between cord 
blood vitamin D levels and the independent variables. Multiple linear regression analysis was 
performed to find the most parsimonious and best fitting model to predict cord blood vitamin D 
levels.  It was performed in three steps: 
   1) The crude analysis included all available data within a variable (most variables had 
some missing data) and involved a bivariate analysis between each independent variable and 
cord blood vitamin D level (the dependent variable).   
  2) A Full Model was created which included all variables from the Crude Model with a p 
< 0.25 (Hosmer and Lemeshow 2000).   
   3) A Reduced Model was created using all variables from the Full Model with a p < 0.10.  
Partial F tests were used to examine whether any variable from the Full Model that was excluded 
from the Reduced Model (i.e because p > 0.10) should be included in the Reduced Model.  
Following this, all variables that were included in the Full Model but excluded from the Reduced 
Model were added individually to the Reduced Model to test for their role as a confounder.  If 
any added variable caused greater than a twenty percent change in the coefficients of the original 
variables, confounding was determined to be present and that variable was retained in the 
reduced model.   
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3.1.4.3 Outcomes Associated with Low Cord Blood Vitamin D Levels 
  The obstetrical and neonatal outcomes of the study population were described.  Mean 
cord blood vitamin D level for each category within each categorical variable was described.  
Independent t-tests were used to compare the mean cord blood vitamin D levels between 
categories for each categorical variable.  Simple linear regression was used to determine whether 
any association existed between continuous variables and cord blood vitamin D levels.  Finally, 
cord blood vitamin D level was used as an independent variable in the prediction of each 
obstetric and neonatal outcome. 
 
3.1.5 Confidentiality and Ethics 
  The protocol Bio 11-185 for the Newborn Vitamin D Study was approved by the 
Research Ethics Board on November 3, 2011 at the University of Saskatchewan as well as by the 
Saskatoon Health Region.  Informed assent/consent was obtained from participants included in 
the study.   For 5 participants, reliable informed consent was not obtained and therefore these 
subjects were excluded from analysis.  Data and samples were coded by study number only and 
stored securely. 
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3.2 RESULTS 
3.2.1 Description of Study Population and Vitamin D Status 
  Of the 89 participants recruited for the study, proper informed consent was not assured 
for five participants and their information was not used in the analysis.  Of the 84 participants 
enrolled in the study, 19 failed to undergo cord blood collection at delivery and their information 
was therefore excluded from the statistical analysis.  For two of these cases, samples were not 
collected due to precipitous deliveries.  For the remaining 17 cases, the reason for failed blood 
collection was unknown but was likely due to a failure to communicate participatory status with 
nurses.  The remaining 65 samples were included in the analysis.   
  Univariate statistics for the sociodemographic variables of all enrolled participants are 
shown in Tables 2 and 3.  Comparisons were made between those who were included in the 
analysis and those who were not because of failed blood collections. There were no statistically 
significant differences between the included and excluded populations.  Overall, 85% of included 
mothers reported taking prenatal supplements and 26% reported taking supplemental vitamin D 
in addition to prenatal supplements.  
 
 
 
Table 2. Categorical Demographic and Obstetric Characteristics of Participants 
 Included 
(n = 65) 
Excluded 
(n = 19) 
 
 Variable n (%) n (%) p-value* 
Residence 
     Rural 
     Urban 
 
21 (32%) 
44 (68%) 
 
6 (32%) 
13 (68%) 
 
0.95 
Mother’s Education Level 
     Elementary or High School 
     Some Post-Secondary 
     Missing 
 
8 (12%) 
55 (85%) 
2 (3%) 
 
5 (26%) 
14 (74%) 
0 
 
0.15 
52 
 
Marital Status 
     Married 
     Single 
     Separated 
     Common-law 
     Missing 
 
43 (66%) 
1 (2%) 
0 
18 (28%) 
3 (5%) 
 
13 (68%) 
1 (5%) 
1 (5%) 
4 (21%) 
0 
 
0.22 
Household Income 
      ≤ $50,000 
     $50,001 - $100,000 
     >$100,000 
    Missing 
 
13 (20%) 
23 (35%) 
21 (32%) 
8 (12%) 
 
5 (26%) 
4 (21%) 
8 (42%) 
2 (11%) 
 
0.45 
Ethnicity of Infant 
     Any Non-White Ethnicity 
     No Non-White Ethnicity 
     Missing 
 
17 (26%) 
43 (66%) 
5 (8%) 
 
6 (32%) 
13 (68%) 
0 
 
0.79 
Parity 
     0 
     1 
     >1 
     Missing 
 
37 (57%) 
19 (29%) 
7 (11%) 
2 (3%) 
 
8 (42%) 
6 (32%) 
3 (16%) 
2 (11%) 
 
0.64 
Prenatal Supplement 
    Yes 
    No 
    Missing 
 
55 (85%) 
7 (11%) 
3 (5%) 
 
11 (58%) 
3 (16%) 
5 (26%) 
 
0.31 
Vitamin D Supplement 
   Yes 
   No 
   Missing 
 
17 (26%) 
44 (68%) 
4 (6%) 
 
1 (5%) 
12 (63%) 
6 (32%) 
 
0.12 
Maternal Medical Condition 
  Yes 
  No 
  Missing 
 
16 (25%) 
48 (74%) 
1 (2%) 
 
5 (26%) 
14 (74%) 
0 
 
0.91 
Illness During Pregnancy 
  Yes 
  No 
  Missing 
 
23 (35%) 
41 (63%) 
1 (2%) 
 
7 (37%) 
12 (63%) 
0 
 
0.94 
* p-value comparing the included to excluded groups 
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Table 3. Continuous Demographic and Obstetric Characteristics of Participants 
 Included 
(n=65) 
Excluded 
(n=19) 
 
Variable Mean 
(SD) 
n (%) Mean 
(SD) 
n (%) p-value * 
Age (years) 29.6 (4.4) 63 (97%) 30.2 (4.3) 9 (47%) 0.67 
Pre-Pregnancy BMI 
(kg/m2) 
25.2 (5.3) 59 (91%) 26.5 (5.7) 18 (95%) 0.37 
Weight Gain During 
Pregnancy (kg) 
13.5 (5.1) 59 (91%)   
Gestational Age 
(weeks) 
39.8 (1.5) 0   
Skin tone forearm (L*) 62.5 (3.5) 52 (80%)   
Skin tone sternum (L*) 63.0 (2.6) 39 (60%)   
* p-value comparing the included to excluded groups
  
  Cord blood vitamin D levels had a relatively normal distribution (Figure 1).  Average 
cord blood vitamin D was 64.1 nmol/L ± 19.8 nmol/L.  Samples ranged from 17.5 nmol/L to 
106.3 nmol/L.  The cord blood vitamin D values were 50.2 nmol/L, 64.2 nmol/L and 78.5 
nmol/L for the 25th, 50th and 75th percentiles respectively.  When compared with previously 
established categories of deficient (<50 nmol/L), insufficient (50-75 nmol/L), and sufficient (>75 
nmol/L) (Holick, Binkley et al. 2011), cord blood vitamin D level was deficient in 22% and 
insufficient in 48% of the 65 newborns studied.   
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Figure 1. Histogram of Cord Blood Vitamin D Levels (n = 65) 
 
 
 
 
3.2.2 Risk Factors for Low Cord Blood Vitamin D Levels 
  Mean cord blood vitamin D level and standard deviation for each level of the categorical 
variables is presented in Table 4.  There was no statistically significant difference in vitamin D 
level between categories for any variable.  However, there was a trend towards higher vitamin D 
levels in those with rural residence (p = 0.09). 
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Table 4. Mean (SD) Levels of Cord Blood Vitamin D by Categorical Independent Variables 
Variable 
 
n (%) Mean Cord Blood 
Vitamin D Level 
(nmol/L) (SD) 
p-value* 
 
Residence 
     Rural 
     Urban 
 
21 (32) 
44 (68) 
 
70.2 (17.8) 
61.2 (20.3) 
 
0.09 
Education 
     Elementary or High School 
     Some Post-Secondary 
 
8 (12) 
55 (85) 
 
61.3 (29.7) 
64.8 (18.3) 
 
0.65 
Marital Status 
     Married 
     Common-law 
 
43 (66) 
18 (28) 
 
65.4 (19.3) 
63.4 (21.2) 
 
0.72 
Income 
     ≤ $50,000 
     $50,001 - $100,000 
     >100,000 
 
13 (20) 
23 (35) 
21 (32) 
 
65.5 (18.6) 
64.5 (22.6) 
67.1 (18.6) 
 
0.91 
Ethnicity of Infant 
     Any Non-White Ethnicity 
     No Non-White Ethnicity 
 
17 (26) 
43 (66) 
 
65.0 (21.7) 
63.9 (19.3) 
 
0.84 
Parity 
     0 
     1 
     >1 
 
37 (57) 
19 (29) 
7 (11) 
 
61.3 (19.2) 
70.6 (18.1) 
63.4 (26.0) 
 
0.20 
Prenatal Supplement 
    Yes 
    No 
 
55 (85) 
7 (11) 
 
65.0 (19.6) 
55.4 (22.4) 
 
0.23 
Vitamin D Supplement 
   Yes 
   No 
 
17 (26) 
44 (68) 
 
65.5 (25.0) 
62.4 (17.0) 
 
0.59 
Maternal Medical Condition 
  Yes 
  No 
 
16 (25) 
48 (74) 
 
67.8 (19.0) 
63.4 (20.0) 
 
0.45 
Illness During Pregnancy 
  Yes 
  No 
 
23 (35) 
41 (63) 
 
63.4 (18.5) 
65.1 (20.5) 
 
0.74 
*p value comparing the vitamin D levels between categories within each variable 
 The r and p-values for the correlation between each continuous independent variable and 
cord blood vitamin D level are presented in Table 5.  Low weight gain during pregnancy was 
associated with low cord blood vitamin D levels (r = 0.27, p = 0.04).  Vitamin D level was not 
significantly correlated with any other maternal demographic or obstetric risk factors.  However, 
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lower maternal age and higher pre-pregnancy BMI showed trends of an association with lower 
cord blood vitamin D levels (p = 0.07 and p = 0.09, respectively). 
 
Table 5. Correlation Between Continuous Variables and Cord Blood Vitamin D Level 
Variable n (%) r value p-value 
Age (years) 63 (97) 0.227 0.07 
Pre-pregnancy BMI (kg/m2) 59 (91) 0.226 0.09 
Less Weight Gain During 
Pregnancy (kg) 
59 (91) 0.274 0.04 
Gestational Age (weeks) 65 (100) 0.085 0.50 
Skin tone forearm (L*) 52 (80) 0.194 0.17 
Skin tone sternum (L*) 39 (60) 0.107 0.52 
  
  The results from the linear regression analyses are presented in Table 6.  This included 
the examination of the association between each risk factor and cord blood vitamin D level at a 
crude level and two levels of adjustment.  The Full Model contains all variables from the Crude 
Model with a p < 0.25, while the Reduced Model contains all variables from the Full Model with 
a p < 0.10 (Age, Rural).  The Full Model has an R2 of 0.344 (p = 0.02) in predicting vitamin D 
levels (n = 41).  The Reduced Model has an R2 of 0.270 (p < 0.01) in predicting vitamin D levels 
(n = 41).  None of the variables included in the full model that were excluded from the reduced 
model affected the β estimate of those variables included in the reduced model.  As such, these 
variables were not included as confounders.
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Table 6. Crude and Adjusted Results from Linear Regression Analyses Predicting Vitamin D Levels 
                                                                                    5
7
 
   Crude  Full (n = 41) Reduced (n = 41) 
Variable  n (%) of 65 β (SE) p-value  β (SE) p-value β (SE) p-value 
Age 63 (97%) 1.016 (0.553) 0.07 1.809 (0.568) <0.01 1.840 
(0.557) 
<0.01 
Rural Address (ref: No) 65 (100%) 9.049 (5.171) 0.09 10.651 
(5.727) 
0.07 9.296 
(5.395) 
0.09 
Pre-pregnancy BMI 59 (91%) -0.844 (0.482) 0.09 -0.759 
(0.628) 
0.24 
Prenatal Supplement 
(ref: No) 
62 (95%) 9.588 (7.983) 0.23 -1.486 
(8.037) 
0.85 
Skin tone forearm (L*) 39 (60%) -1.045 (0.746) 0.17 -1.084 
(0.729) 
0.15 
Weight Gain During 
Pregnancy (kg) 
59 (91%) 1.047 (0.488) 0.04 0.573 (0.583) 0.33 
Post-secondary 
Education (ref: No) 
63 (97%) 3.487 (7.537) 0.65 
Marital Status 62 (95%) -0.506 (1.393) 0.72 
Household Income 53 (82%) 1.004 (3.523) 0.78 
Non-white Ethnicity 60 (92%) 1.137 (5.735) 0.84 
Parity 63 (97%) 3.534 (3.633) 0.33 
Vitamin D Supplement 
(ref: No) 
61 (94%) 3.051 (5.562) 0.59 
Maternal Medical 
Condition (ref: No) 
64 (98%) 4.330 (5.700) 0.45 
Illness During 
Pregnancy (ref: No) 
64 (98%) -1.737 (5.163) 0.74 
Gestational Age 
(weeks) 
65 (100%) -1.151 (1.700) 0.50 
Skin tone sternum (L*) 39 (60%) -0.810 (1.240) 0.52 
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3.2.3 Outcomes Associated with Cord Blood Vitamin D Levels 
  The obstetric and neonatal outcomes that occurred among participants (n = 65) are 
presented in Tables 7 and 8.  Most participants had vaginal births (82%) and most of their infants 
(85%) did not have any illness or require any medical intervention at birth.  Their infants had a 
mean length of 52.8 ± 2.9cm, a mean weight of 3616 ± 523g, a mean head circumference of 34.9 
± 1.4cm, and mean Apgar scores of 7.8 ± 1.6 at 1 minute and 8.8 ± 0.6 at 5 minutes. Apgar score 
at 10 minutes was not considered due to the large number of missing values (Table 8). 
Table 7. Frequency (%) of Categorical Obstetric and Neonatal Outcomes (n = 65) 
Variable n (%) of 65 
Method of Delivery  
        Vaginal 
        Cesarean 
 
53 (82%) 
12 (19%) 
Delivery Complication  
        Yes 
        No 
        Missing 
 
28 (43%) 
34 (52%) 
3 (5%) 
Infant Illness at Birth  
        Yes 
        No 
        Missing 
 
7 (11%) 
55 (85%) 
3 (5%) 
 
 
Table 8. Descriptives of Continuous Obstetric and Neonatal Outcomes (n = 65) 
Variable  Mean (SD) Missing         
n (%) of 65 
Infant Length (cm) 52.8 (2.9) 0 
Infant Weight (g) 3616 (523) 0 
Infant Head Circumference (cm) 34.9 (1.4) 0 
Apgar 1 minute 7.8 (1.6) 0 
Apgar 5 minute 8.8 (0.6) 0 
Apgar 10 minute 8.2 (1.0) 59 (91%) 
 
  The mean cord blood vitamin D level and standard deviation for each categorical variable 
are presented in Table 9.  There was no significant difference between categories within each 
variable.  
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Table 9. Mean (SD) Levels of Cord Blood 25(OH)D Stratified by Categorical Variables 
Variable Mean Cord Blood 
Vitamin D Level 
(nmol/L) (SD) 
p-value* 
 
Method of Delivery  
        Vaginal 
        Cesarean 
 
63.2 (21.2) 
67.8 (12.0) 
 
0.47 
Delivery Complication  
        Yes 
        No 
 
63.8 (17.1) 
63.3 (21.4) 
 
0.92 
Infant Illness at Birth  
        Yes 
        No 
 
74.1 (18.3) 
62.1 (19.3) 
 
0.12 
*p value comparing the vitamin D levels between categories within each variable 
 
  The r and p-values for the correlation between each continuous independent variable and 
cord blood vitamin D level are presented in Table 10.  Vitamin D level was not significantly 
associated with any neonatal outcomes.   
Table 10. Correlation Between Continuous Variables and Cord Blood 25(OH)D 
Variable R value p-value 
Infant Length (cm) 0.054 0.67 
Infant Weight (g) 0.113 0.37 
Infant Head Circumference (cm) 0.029 0.82 
Apgar 1 minute 0.159 0.21 
Apgar 5 minute 0.128 0.31 
  
 Vitamin D level was investigated as a risk factor for various obstetric and neonatal 
outcomes.  Vitamin D level was not significantly associated with any obstetric or neonatal 
outcomes including Cesarean delivery (OR = 1.002, 95% CI = 0.998 – 1.006, p-value = 0.47), 
delivery complications (OR = 0.000, 95% CI = 1.006 – 0.994, p-value = 0.92), infant illness at 
birth (OR = 1.003, 95% CI = 1.007 – 0.999, p-value = 0.12), infant length (β = -0.008, SE = 
0.018, p-value = 0.67), infant weight (β = -2.973, SE = 3.305, p = 0.37), infant head 
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circumference (β = -0.002, SE = 0.009, p = 0.82), Apgar 1 minute (β = -0.013, SE = 0.010, p = 
0.21), and Apgar 5 minute (β = -0.004, SE = 0.004, p = 0.31).   
 
3.2.4 Analysis of Statistical Power 
  This post-hoc analysis estimated the power achieved for all categorical variables with a 
between-group significance of p < 0.25.  The categorical variable with the highest power was 
“Residence,” which had an effect size of 0.47, a power of 42% and would have required a 
sample size of 160 participants to achieve a power of 80%.   “Infant Illness at Birth” had an 
effect size of 0.64, a power of 35% and would have required a sample size of greater than 200 
participants to achieve a power of 80%.  “Parity” had an effect size of 0.21, a power of less than 
30%, and would have required a sample size of 228 to achieve a power of 80%, while “Prenatal 
Supplement” had an effect size of 0.45, a power of 20% and would have required a sample size 
of more than 400 to achieve a power of 80%.  Because all other categorical variables had lower p 
values than the four described above, these variables would have required much higher sample 
sizes to achieve a power of 80%.  Therefore, if a statistically significant difference was present in 
the population, our study was inappropriately powered to detect it most of the time.  In the best 
scenario, for the variable “Residence,” a power of 42% means that our probability of committing 
Type II error was 58% (our study would not detect a significant difference if one was present 
58% of the time).   
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3.3   DISCUSSION 
“Readers of medical literature need to consider two types of validity, internal and external. 
Internal validity means that the study measured what it set out to; external validity is the ability 
to generalise from the study to the reader’s patients.” 
-David A Grimes and Kenneth F Schulz, The Lancet, 2002 
 
3.3.1 Interpretation of Results  
3.3.1.1 Prevalence of Cord Blood Vitamin D Insufficiency and Deficiency 
  The estimated prevalence of cord blood vitamin D deficiency and insufficiency in the 
Saskatoon Health Region was lower than the prevalence reported by other Canadian studies.   In 
Winnipeg, 36% of 50 infants had deficient cord blood vitamin D levels (deficiency defined as    
< 27.5 nmol/L) (Weiler, Fitzpatrick-Wong et al. 2005), in the Northwest Territories, the average 
newborn cord blood vitamin D level was deficient (n = 121, deficiency defined as < 50 nmol/L) 
(Waiters, Godel et al. 1999), and in Newfoundland, 35% and 49% of 51 infants had deficient 
(defined as < 50 nmol/L) and insufficient (defined as 50 – 75 nmol/L) cord blood vitamin D 
levels, respectively (Newhook, Sloka et al. 2009).  Given the Saskatoon population’s many risk 
factors for having low levels of vitamin D, it was expected that the prevalence of vitamin D 
deficiency and insufficiency in our study population would be similar to or higher than the 
prevalence found in other Canadian studies.  Results indicated that 22% and 48% of our 65 
newborns had deficient (< 50 nmol/L) and insufficient (50 – 75 nmol/L) cord blood vitamin D 
levels, respectively.  While the prevalence of cord blood vitamin D deficiency and insufficiency 
in the Saskatoon Health Region was estimated to be lower than the prevalence reported in the 
other Canadian studies, it is possible that our study underestimated the prevalence of vitamin D 
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insufficiency and deficiency (see Sections 3.3.1 and 3.3.2). 
  Similar to many previous studies, our study found that the 400 IU per day contained in 
prenatal vitamins was not sufficient to produce sufficient maternal and cord blood levels of 
vitamin D.  For example, in Vancouver, Li et al. found that although 80% of 336 pregnant 
women took a vitamin D-containing supplement containing ≥ 400 IU of vitamin D, 24% and 
65% of women had deficient (< 50 nmol/L) and insufficient (< 75 nmol/L) serum levels of 
vitamin D, respectively (Li et al., 2011).  Bodnar et al. found that although 90% of women used 
prenatal vitamins in the last trimester of pregnancy, vitamin D deficiency (cord blood vitamin D 
levels < 37.5 nmol/L) and insufficiency (cord blood vitamin D levels 37.5 – 80 nmol/L) occurred 
in 45.6% and 46.8% of black neonates and 9.7% and 56.4% of white neonates (Bodnar, Simhan 
et al. 2007).  Additionally, Dror et al. found that of the mothers who took a daily prenatal 
supplement containing 400 IU of vitamin D, 50% had a serum vitamin D concentration that was 
either insufficient or deficient (<75 nmol/L) (Dror, King et al. 2011).   Similarly, this study 
showed that despite daily prenatal multivitamin use by 85% of mothers (typically containing 400 
IU of vitamin D) and additional vitamin D supplements taken by 26% of mothers, 22% of 
newborns were deficient and 48% were insufficient in their cord blood vitamin D levels.  
Maternal vitamin D supplementation of 400 IU per day was not enough to prevent vitamin D 
insufficiency and deficiency in most newborns.  This finding highlights the need for an urgent 
revision of maternal vitamin D supplementation guidelines in order to produce sufficient cord 
blood vitamin D levels in newborns. 
 
3.3.1.2 Risk Factors for Cord Blood Vitamin D Insufficiency and Deficiency 
  Our study aimed to determine whether any socio-demographic, obstetric, or personal 
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health risk factors existed for low cord blood vitamin D levels in our study population.  Each 
categorical variable was tested to determine whether a significant difference existed between 
mean cord blood vitamin D levels for each category within each variable (see Table 4).  
Although there was no significant difference in mean cord blood vitamin D levels between 
categories for each categorical variable, there was a trend towards higher levels of vitamin D in 
those with a rural area of residence compared with an urban area of residence (p = 0.09).   
  The finding of a trend towards higher levels of vitamin D in those with a rural area of 
residence may be due to higher socioeconomic status, better diet and genetic differences between 
Caucasian and darker-skinned ethnicities.  Bedroom communities that are a short distance from 
Saskatoon likely have populations with a higher socioeconomic status who commute into 
Saskatoon for employment.  Those with higher socioeconomic status are more likely to consume 
vitamin D-rich foods (Laitinen, Rasanen et al. 1995; Rasanen, Kronberg-Kippila et al. 2006).  As 
well, according to the 2011 Statistics Canada census, rural towns, such as Dundurn and 
Rosetown, have predominantly Caucasian populations based on their reported mother tongues 
and languages spoken at home (Statistics Canada, 2011).  While the increased absorption of 
vitamin D from sunlight in Caucasians would normally help to explain differences in vitamin D 
levels between Caucasian and non-Caucasian populations, our study was conducted during the 
winter months, and therefore this effect should have been negligible.  Instead, genetic differences 
between Caucasians and darker-skinned ethnicities may aid in explaining differences in vitamin 
D levels, but little research exists to confirm this hypothesis. 
 Bivariate analysis revealed that low weight gain during pregnancy was associated with 
low cord blood vitamin D levels (R = 0.274, p = 0.04).  It also indicated that lower maternal age, 
higher pre-pregnancy BMI, and urban area of residence were modestly associated with lower 
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cord blood vitamin D levels (p = 0.07, p = 0.09, and p = 0.09, respectively).  The association of 
low vitamin D levels with urban area of residence is discussed above.  High BMI is a well-
established risk factor for having low levels of vitamin D (Bell, Epstein et al. 1985; Wortsman, 
Matsuoka et al. 2000; Arunabh, Pollack et al. 2003), as the fat-soluble vitamin becomes 
sequestered in the fat and is subsequently physiologically unavailable.  As well, high pre-
pregnancy BMI has been associated with low pregnancy and neonatal vitamin D levels in a study 
involving 400 mother-infant dyads (Bodnar, Catov et al. 2007).  It is possible that participants 
with higher BMIs gained less weight during pregnancy and that this could account for the low 
vitamin D levels among those with low weight gain during pregnancy.  This hypothesis is likely, 
as a bivariate analysis using pre-pregnancy BMI as a predictor for weight gain during pregnancy 
reveals a strong trend between the two variables given the small sample size (n = 56, p = 0.07).  
It is also possible that those with a low weight gain during pregnancy had an inadequate diet to 
produce both normal weight gain and sufficient vitamin D levels.  
  Low maternal age has been associated with cord blood vitamin D status in previous 
literature.  Younger maternal age was associated with lower neonatal vitamin D status in a New 
Zealand study involving 929 newborns (Camargo, Ingham et al. 2010) as well as in an Australian 
study involving 901 newborns (Bowyer, Catling-Paull et al. 2009).  One author speculated that 
younger mothers may be less compliant with prenatal vitamins or may have less sun exposure 
(Camargo, Ingham et al. 2010).  It is also possible that younger mothers may have a smaller 
income than older mothers and may consume less expensive, less nutritious foods. 
  The linear regression model which best predicted cord blood vitamin D levels included 
only maternal age and rural area of residence.  This likely differs from the bivariate analysis due 
to confounders which affect the relationship between the independent variables and the 
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dependent variable (cord blood vitamin D level).   
 
3.3.1.3 Vitamin D Level as a Predictor for Obstetric and Neonatal Outcomes 
  Cord blood vitamin D level did not significantly predict any obstetric and neonatal 
outcomes.  There is little literature that examines the role of cord blood vitamin D levels in the 
prediction of infant health outcomes, but a substantial body of literature supports the role of 
maternal vitamin D intake in predicting birth weight and length (Sabour 2006; Scholl and Chen 
2009; Leffelaar, Vrijkotte et al. 2010).  It is possible that with a larger sample size, an association 
between cord blood vitamin D levels and obstetric or neonatal outcomes may become apparent.  
It is also possible that “normal” vitamin D levels for children differ substantially from “normal” 
vitamin D levels for adults.  Although some research conducted in children and adolescents 
indicates that normal levels of vitamin D for children may be the same as they are for adults 
(Guillemant, Taupin et al. 1999; Cheng, Tylavsky et al. 2003; Abrams, Griffin et al. 2005), little 
or no research has been performed in neonates, infants or small children.  In fact, one author 
argues that because cord blood vitamin D samples typically contain 50-60% of maternal vitamin 
D concentration, “normal” cord blood vitamin D concentration may be >40 nmol/L (Roth 2007).  
Further research on the clinical implications of cord blood vitamin D deficiency or insufficiency 
must be conducted before age-specific reference ranges are established. 
 
3.3.2 Assessment of External Validity 
  The assessment of external validity will compare the study population with the general 
population and comment on the presence and effect of selection bias. 
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3.3.2.1 Comparison of Study Population with General Population 
  The median income of the population under investigation is similar to the median income 
of Saskatoon’s general population.  In 2010, the median family income in Saskatoon was 
$80,570 (Statistics Canada 2009).  In this study, 32% of participants reported a household 
income of greater than $100,000, 35% reported a household income of $50,001 - $100,000, and 
20% reported a household income of less than $50,000.  Therefore, median income in the study 
population was in the range of $50,001 - $100,000, which is similar to the median family income 
of $80,750 reported for the general population.    
  The study population is also similar to the Saskatoon Health Region population in terms 
of ethnicity, area of residence, and maternal age at delivery.  The most recent census data for 
Saskatoon indicated that 17.2% of Saskatoon’s population had some non-white ethnicity 
(Statistics Canada 2006), 73% of the Saskatoon Health Region population lived in the city of 
Saskatoon (Neudorf 2009), and the highest fertility rates for women in the Saskatoon Health 
Region were in the age groups of 25-29 and 30-34, respectively (Neudorf 2009).  In comparison, 
26% of our study participants indicated that their newborn had some non-white ethnicity, 68% 
indicated an urban area of residence, and our study population had a mean maternal age of 29.6 ± 
4.4 years.  Therefore, for a small sample size, the incomes, ethnicities, area of residence and 
mean maternal age at delivery of the study population closely matched those of the general 
population in the Saskatoon Health Region. 
  Differences between the general population and the study population were most 
prominent in maternal educational level and marital status.  In 2006, 46% of adult women living 
in Saskatchewan had some form of post-secondary education and 55% had elementary or high 
school education (Saskatchewan Ministry of Advanced Employment and Labour 2009).  In this 
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study, 85% of women reported some post-secondary education, while only 12% reported 
elementary or high school education.  An analysis of data collected from 5,643 mothers between 
1992 and 1994 indicated that 27.3% of pregnant women had never been married, while 70.5% 
were currently married (Jackson 2003).  In our study, 94% of participants indicated their marital 
status as either “married” or “common-law.”  These differences in educational and marital status 
between study and general populations may indicate either a response bias or a genuine 
difference between populations.  In any case, both education level and marital status may be 
regarded as socioeconomic indicators, and low socioeconomic status is a risk factor for having a 
low level of vitamin D (Laitinen, Rasanen et al. 1995; Rasanen, Kronberg-Kippila et al. 2006).  
Our study population indicated that they were more educated and more likely to be married than 
the general population.  If our study population has a higher socioeconomic status than the 
general population, we may have underestimated the prevalence of vitamin D deficiency and 
insufficiency in the newborn population of the Saskatoon Health Region. 
 
3.3.2.2 Sampling Bias    
  Sampling bias is a type of selection bias which causes some members of the population to 
be less likely to be included than others due to a non-random selection of participants.  This type 
of bias refers to a skewing of the results due to the inclusion of study population that is not 
reflective of the general population.   
   The study design may have favoured a healthier population.  Potential participants were 
recruited at prenatal tours as well as on the Labour and Delivery ward at Royal University 
Hospital.  While the population present at prenatal tours (and the population who receives any 
prenatal care) tends to be a healthier, higher income, and more educated sub-section of the 
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population, it was hoped that recruitment on Labour and Delivery would allow for the inclusion 
of more marginalized sections of the population.  Although the women who chose to participate 
in the study were more educated and more likely to be married than the general population, they 
were similar to the general population in terms of income, ethnicity, area of residence, and 
maternal age at delivery (see Section 3.3.2 Assessment of External Validity).  Women who are 
more educated may be more likely to consume nutrient-rich foods, and this may skew results in 
favour of an underestimation of low levels of vitamin D in the general population.  However, due 
to the voluntary nature of participation in this study, this bias could not be controlled for. 
 The study design specifically excluded individuals with medical conditions or drugs that 
might affect calcium or vitamin D levels.  The exclusion criteria of the study ensured that all 
mothers with thyroid or parathyroid problems, problems with calcium regulation, or those who 
took medications that would interact with calcium regulation were excluded.  Therefore, in the 
absence of any undiagnosed conditions that may interfere with calcium or vitamin D regulation, 
the study population did not have any medical conditions that would have skewed the results.  
However, the general population has a small percentage of people with calcium regulation 
problems who were not represented in our study.  This bias is likely irrelevant in a population 
with a small sample size. 
 
3.3.3 Assessment of Internal Validity 
   “Bias undermines the internal validity of research” (Grimes 2002).  Research bias refers 
to deviation of the research results from the truth.  Many types of bias in study design, 
implementation and interpretation exist.  The following type of bias are often present in 
observational studies: selection bias, information bias, and confounding (Grimes 2002).  In this 
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study, a single group was enrolled, the prevalence of an outcome (low cord blood vitamin D 
levels) was estimated, and associations between that outcome and several independent variables 
were examined.  The following section will therefore explore selection bias, information bias and 
confounding in the context of this study. 
 
3.3.3.1 Information Bias 
  This type of bias results from the incorrect determination of exposure or outcome, or both 
(Grimes 2002).   
  Missing maternal demographic data ranged between 0 – 12% for each variable measured 
by the Participant Questionnaire (see Table 2), and this may have skewed the outcomes 
measured in the study.  A number of participants chose not to answer questions concerning their 
age, marital status, education level, household income and ethnicity, among other questions.    As 
well, some information, such as weight gain during pregnancy, was not always present in the 
medical records.  The Participant Questionnaire stated clearly that participants did not have to 
answer any questions that they feel uncomfortable answering, and this may have been one reason 
that participants chose not to answer certain questions.  It is also possible that participants felt a 
lack of anonymity with their responses, as the questionnaires were collected from them 
personally by the researcher (despite no names being present on the questionnaire itself).  This 
type of bias could potentially be avoided in the future by providing participants with a postage-
paid, addressed envelope so that questionnaires could be mailed in anonymously (identified only 
by participant number).  Although the missing data may have skewed the results towards more 
socially acceptable responses, this is unlikely given the small amount of missing data for each 
variable. 
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  The demographic information of the included participants (n = 65) did not differ 
significantly from the demographic information of the excluded participants (n = 19) (see Tables 
2 and 3).  Therefore, the exclusion of those participants from the analysis likely did not bias the 
data.  As well, because samples were not collected from 19 participants, these participants were 
not followed post-partum and no information is available about their obstetric or neonatal 
outcomes.  It is therefore impossible to compare the included to the excluded groups in terms of 
obstetric and neonatal outcomes.  However, given their demographic similarity, the missing data 
likely did not significantly skew the available data.  Future studies could avoid this problem 
through a study design that improved communication with labour and delivery staff so that 
samples were not missed.   
  Information about the mother’s occupation was collected but not analyzed.  The Statistics 
Canada categories for occupation did not include “Homemaker” and it could not be discerned 
whether participants had previously been or were currently working outside the home.  As well, 
many participants chose several categories or indicated “Other,” making it very difficult to 
analyze these results.  This could be avoided by asking, “Do you work outside the home?” 
(Yes/No) prior to asking the participants to choose the single Statistics Canada category that best 
describes their occupation.  Because occupation is used as an indicator of socioeconomic status 
(and low socioeconomic status is a risk factor for low levels of vitamin D), it is possible that an 
association would have been present between employment status and cord blood vitamin D 
levels.  However, income and education level, other indicators of socioeconomic status, were 
analyzed and were not significantly associated with cord blood vitamin D levels. 
  3.3.3.1.1 Accuracy of Collected Data:  The Participant Questionnaire was answered 
directly by participants and asked participants to answer only questions they felt comfortable 
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answering.  This may have led to some non-response bias.  As well, some questions were 
difficult to answer.  For example, “Maximum Education Level” was listed in 6 categories: 
“elementary,” “high school,” “some university,” “technical training beyond high school,” “one 
or more university degrees,” or “other (list).”  These categories were loosely based on the 
Statistics Canada 2006 Census.  However, those who chose “other” were left without an 
analyzable category.  Also, the term “technical training beyond high school” makes any non-
university training, such as a Basic Life Support course, equivalent to a college degree.  In this 
study, due to the small sample size, Education Level was reduced to “Elementary or high 
school,” and “Some post-secondary education.”  Future studies would do better to use the 
categories “elementary,” “high school,” “training other than college or university,” “college 
degree,” and “university degree.”   
  The Questionnaire asked whether or not participants took an “additional vitamin D 
supplement” but did not ask about prenatal supplements.  Due to this lack of clarity, the 
researcher asked each participant directly about her prenatal supplement use and vitamin D 
intake in order to quantify the amount of vitamin D taken.  This could be avoided through the use 
of two separate questions stating, “Did you take a daily prenatal supplement?” and “Did you take 
an additional vitamin D supplement?” 
  The data collected for ethnicity was difficult to interpret.  Participants were instructed to 
select all ethnicities that applied to their newborns (ethnic groups listed according to the 
Statistics Canada 2006 Census).  Several ethnicities were often selected, and this makes 
ethnicities present several generations ago equivalent to ethnicities present within one 
generation.  For the purposes of analysis, this data was reduced to “No non-white ethnicity,” and 
“Any non-white ethnicity” based on the ethnicities listed.  Non-white ethnicities included East 
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and Southeast Asian, Aboriginal, Chinese, South Asian, American Indian, East Indian, 
Caribbean or Arab origins (Statistics Canada 2006).  The question could be clarified by asking 
participants if they or their partners would identify themselves as visible minorities, as the 
purpose of the question was to search for an association between darker skin tones and lower 
vitamin D levels.   
  As previously mentioned, the Statistics Canada categories for maternal occupation were 
difficult to use.  It would have been useful to include the question, “Do you work outside the 
home?” as there was no option for “Homemaker.”  The question that asked participants to list 
any infections or illnesses during pregnancy could have been clarified by asking participants to 
list only infections or illnesses which required antibiotics or other medical treatment.  Finally, the 
term “household income” was unclear because it did not specify gross or net income.   
  Although the Participant Questionnaire could have been clearer, the collection of data 
from participants was standardized.  All participants were asked to fill out the Participant 
Questionnaire and asked directly about their prenatal supplement use and vitamin D intake by the 
researcher.  After delivery, participant and newborn medical charts were consulted to obtain all 
obstetric and newborn outcome information.  Although different health care providers may have 
completed different charts, this information was likely unbiased as the physicians caring for the 
participants had no knowledge or consideration of the study.   
  Finally, the dependent variable, vitamin D, was objectively measured by a lab technician 
who had no knowledge of participants as samples were identified by participant number only.  
Levels were determined by enzyme immunoassay (Immunodiagnostic Systems Ltd.) which were 
run in accordance with the manufacturer’s specifications.  Vitamin D External Quality 
Assessment Scheme (DEQAS; www.deqas.org) samples were run in parallel with subject 
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samples. 
  In conclusion, although the socio-demographic information could have been collected 
through clearer questions on the Participant Questionnaire, the questions were identical for all 
participants.  There may have been some non-response bias which could not be controlled for.  
Vitamin D intake was the only question assessed directly by the researcher.  The obstetric and 
neonatal outcome information derived from medical charts was likely unbiased and the cord 
blood vitamin D levels were assessed objectively.   
 
3.3.3.2 Confounding 
  Confounding occurs when a third factor interferes with a relationship between an 
independent variable and the outcome variable.  A confounding factor is associated with the 
independent variable and effects the outcome variable (Grimes 2002).  These relationships 
should always be assessed when critically appraising research.  By completing an adjusted 
analysis, we attempted to control for potential confounders. 
  All variables included in the full model but not initially in the reduced model were added 
individually to the Reduced Model (see Table 6) to test for confounding and because no 
variables significantly changed the β values of the variables in the Reduced Model, it was 
concluded that no confounders were present in the data set.  However, the small sample size may 
have masked confounding that would have been significant with a larger data set.  As well, 
variables outside the data set may have been confounders that were not controlled for. 
  For example, diet and sun exposure were not measured in the study population and may 
have acted as confounders.  Future studies may rectify this by taking detailed diet histories or 
asking participants to recollect how much time was spent outdoors.  Given that the study was 
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conducted over the winter months, sun exposure was likely minimal for all participants.  Diet 
histories, however, may have been a worthwhile endeavour. 
  In this study, each categorical variable creates several groups of participants being 
studied, and these groups cannot be compared to each other without accounting for confounding 
variables.  For example, those with income < $50,000 may be have differences from those with 
incomes $50,000 - $100,000 and > $100,000 other than income.  They may have lower education 
levels, take fewer prenatal supplements or vitamin D supplements, have an increased risk of 
illness during pregnancy or have different ethnicities than those with higher incomes.  Unless 
those variables are accounted for, any association between vitamin D level and income is 
assumed to be directly related to income.  Therefore, bivariate analysis may be misleading, as it 
attributes causation to only a single variable.  Multivariate model building controls for all 
potential confounders included in the model and decreases the risk of selection bias.   
  In this study, although bivariate analysis was used in the initial testing of variables, a 
multivariate model was later used which controlled for many confounding variables.  However, 
other differences between groups within each variable, such as better response rates, cannot be 
measured, as it is impossible to know whether participants with missing data belonged to one 
group or another.  This response bias could not be controlled for. 
 
3.3.3.3 Sample Size and Statistical Power 
  Statistical power is the probability of rejecting the null hypothesis when it is false (the 
probability of not making a Type II error).  Power is influenced by the sample size, the effect 
size and the levels of error we are willing to accept (significance criterion).  Effect size refers to 
the detectable difference in the outcome variable between groups (a higher-powered study will 
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detect smaller differences in the outcome variable).  Given that the significance criterion 
commonly used by the scientific community is 0.05, there is only a 5% chance that any study 
using this criterion will find a false positive result (Type I, or α, error).  Power may be increased 
(and Type II error decreased) by increasing the significance criterion (for example, to p = 0.10), 
but this increases the risk of Type I error.  The accepted balance between Type I and Type II 
errors is to use a significance criterion of 0.05.   
  Most researchers consider a power of 80% adequate, as this achieves a 4-to-1 trade-off 
between Type II (β) and Type I (α) error (β = 0.20, α = 0.05) (Hulley, Cummings et al. 2007).  
However, the choice of power level and alpha depends on the type of study, as studies reporting 
adverse events require the highest possible power to avoid Type II error, while studies reporting 
the success of a treatment should minimize alpha and Type I error.  While a significance 
criterion of α = 0.05 was used for this study, the post-hoc analysis of statistical power showed 
that a power of 80% was not achieved for any categorical variable due to small sample size. 
  A conservative post-hoc analysis uses categorical rather than continuous variables to 
estimate power, as categorical variables generally have lower power than continuous variables 
(Hulley, Cummings et al. 2007).  Our power analysis (Section 3.2.4) estimated the power 
achieved for all categorical variables with a p < 0.25 and indicated that our probability of 
committing Type II error was very high (58% for the highest-powered categorical variable) due 
to our small sample size.  Therefore, a larger sample size may be necessary to rule out the role of 
chance in this study.  Despite this, the effect sizes observed with the aforementioned variables, 
other than “parity”, in this study were all greater than 0.45 indicating a moderate effect size. 
  Lower power may also indicate that any difference detected by our study may be very 
likely to be present in the general population (our study only detects large differences).  
76 
 
However, given the number of comparisons made during bivariate analysis, it is equally likely 
that those findings of significance are due to chance.  For example, if 20 independent variables 
are tested at an α = 0.05, there is a very high probability of making a Type 1 error (64%, or 1 – 
0.9520) (Hulley, Cummings et al. 2007).  While an adjustment for multiple comparisons would 
control for this error, the Bonferroni approach, which divides the significance level by the 
number of hypotheses tested, is usually too stringent.  The Bayesian approach asserts that if each 
individual variable has a reasonable probability of being correct based on previous research, no 
adjustment for multiple comparisons is necessary (Hulley, Cummings et al. 2007).  In this study, 
each variable was included based on the results of previous research and physiological 
plausibility.  This study was also exploratory in nature.  Therefore no adjustment for multiple 
comparisons was made. 
 
3.3.4 Other Strengths and Limitations 
  Due to the lack of data about the risk factors and neonatal outcomes associated with cord 
blood vitamin D levels, this study was exploratory in its intent.  This study assessed sixteen 
potential socio-demographic and personal health risk factors and eight potential obstetric and 
neonatal outcomes for association with cord blood vitamin D level.  In the assessment for risk 
factors, there was no correction for multiple comparisons because the bivariate analysis was only 
used as a basis for multivariate model building.  All variables with a p < 0.25 in bivariate 
analysis were included in a Full Model, and all variables from the Full Model with a p < 0.10 
were included in the Reduced Model.  Due to the small sample size (n = 41 due to missing data) 
and the small number of variables in the Full and Reduced Models (six and two variables, 
respectively), no adjustment for multiple comparisons was made.  Furthermore, none of the 
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variables included in the full model that were excluded from the reduced model affected the β 
estimate of those variables included in the reduced model.   Therefore, no confounding was 
found to exist. 
 No neonatal outcomes had statistically significant associations with vitamin D levels 
during the bivariate analysis and therefore no model building was pursued. 
  The small sample size of this study indicates that the study has little power, or little 
probability of not making Type II error (falsely accepting the null hypothesis).  A study with 
little power has limited ability to detect associations that are present.  However, this also means 
that any statistical significance detected denotes a stronger association between the independent 
and dependant variables.  Therefore, the association of younger maternal age and urban area of 
residence with low cord blood vitamin D levels is likely to be strong in this population.  A larger 
sample size may be necessary to confirm or refute this finding as well as ascertain whether 
further risk factors are associated with low cord blood levels of vitamin D. 
  The largest strength of this study was that the data is likely to be both reliable (precise 
and reproducible) and valid (reflective of the general population).  Obstetric and neonatal 
outcomes as well as cord blood vitamin D levels were measured objectively.  Although the 
measurement of socio-demographic factors was subject to non-response bias, the measurement 
was standardized for all participants.  The prevalence of cord blood vitamin D deficiency and 
insufficiency in the study population is likely to be either reflective or an underestimation of that 
in the general population.  Although a larger sample size would be necessary to help rule out the 
role of chance to determine whether any risk factors or neonatal outcomes are associated with 
cord blood vitamin D levels, this small study’s negative results are likely to be reproducible. 
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3.3.5 Conclusions and Future Research Directions 
  Adequate vitamin D supplementation during pregnancy is likely a factor important to 
ensuring optimal health outcomes for offspring.  Despite a compelling body of research showing 
that vitamin D deficiency is prevalent among both mothers and infants in Canada and worldwide  
(see Sections 2.2.2 and 2.3.1), the problem of widespread vitamin D deficiency remains 
insufficiently addressed.  Researchers are only now beginning to appreciate the potential clinical 
and economic implications of in utero vitamin D deficiency; studies have linked maternal 
vitamin D levels with chronic diseases such as asthma (Devereux, Litonjua et al. 2007; Erkkola, 
Kaila et al. 2009) and type 1 diabetes (Krishnaveni, Veena et al. 2011) in the offspring.   Vitamin 
D’s associations with infection, autoimmune disease, cancer, and bone health are better 
understood, and low vitamin D status throughout life is associated with adverse health outcomes.  
In fact, one study estimated that optimizing vitamin D levels in Canadians could reduce mortality 
by 37,000 annually (a 16.1% reduction) and reduce the annual economic burden by $14.4 billion 
(6.9%) (Grant, Schwalfenberg et al. 2010).  Given the health and economic benefits afforded to 
the very inexpensive supplement, the prevention of low levels of vitamin D should be a priority 
for the medical and public health fields as well as the general public.  Sufficient vitamin D status 
should begin in utero and be maintained throughout life.   
  Our research estimates that the prevalence of vitamin D deficiency and insufficiency 
among newborns in the Saskatoon Health Region is 22% and 48%, respectively.  The 
population’s many risk factors for low vitamin D levels, including its northern latitude, lack of 
sun exposure during the winter months, high Aboriginal population and high prevalence of 
obesity may aid in explaining these results.  However, similar results have been found in warmer 
climates that lack some or all of these risk factors (Bowyer, Catling-Paull et al. 2009; Dror, King 
et al. 2011), which presents a stronger case for the role of maternal diet and supplementation in 
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preventing low newborn levels of vitamin D.  The provision of adequate maternal vitamin D 
supplementation may represent a tremendous opportunity for health and economic gain in 
Saskatoon and around the world.  
  A lack of research that demonstrates safe and effective vitamin D dosages during 
pregnancy has impeded consensus on maternal vitamin D supplementation guidelines.  Health 
Canada, the Endocrine Society, and the Canadian Pediatric Society have different 
recommendations for vitamin D supplementation during pregnancy (see Section 2.2.1).  Further 
randomized-controlled trials of vitamin D supplementation in pregnancy may be necessary prior 
to any consensus being reached.   
  A review of recent literature as well as the results of this study suggest that 400 IU of 
vitamin D per day is insufficient to prevent vitamin D deficiency and insufficiency in mothers 
and newborns (Bodnar, Simhan et al. 2007; Ward, Gaboury et al. 2007; Dror 2011; Li 2011).  A 
recent randomized controlled trial demonstrated the safety and efficacy of 4,000 IU of vitamin D 
per day during pregnancy (Hollis, Johnson et al. 2011), and another study showed that doses of 
up to 10,000 IU per day did not elevate vitamin D levels into the toxic range (Hollis and Wagner 
2004).  Although the Endocrine Society recommends a dose of 600 IU of vitamin D per day for 
pregnant and lactating women, it also recognizes that doses of up to 1500 – 2000 IU per day may 
be necessary to maintain a serum vitamin D level of greater than 75 nmol/L (Holick, Binkley et 
al. 2011).  The Canadian Pediatric Society’s recommendation of 2000 IU per day for pregnant or 
lactating women (Canadian Pediatric Society 2007) is based on a recent literature review and 
should perhaps be adopted by other agencies.  However, further research is needed to confirm 
this recommendation or to aid the creation of new guidelines for maternal vitamin D 
supplementation. 
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  Maternal vitamin D supplementation guidelines may need to be stratified according to 
risk factors.  Skin colour, BMI, sun exposure and a lack of dietary vitamin D consumption are all 
well-recognized risk factors for having low levels of vitamin D.  As well, genotype may play a 
role in modulating vitamin D levels and requirements.  Mothers with darker skin, mutations in 
vitamin D-specific proteins, and other risk factors for having a low level of vitamin D may 
require higher levels of supplementation than mothers without risk factors.  Our research 
indicates that young, urban mothers in the Saskatoon Health Region are at the highest risk of 
having infants with a low cord blood vitamin D level, but further research is necessary to 
confirm or refute this observation.  
  The role of vitamin D in fetal and neonatal life has yet to be elucidated.  Our research 
found no association between low neonatal vitamin D levels and obstetric or neonatal outcomes.  
It is possible that this lack of association is because age-specific reference ranges for vitamin D 
levels have yet to be determined.  “Normal” vitamin D levels for neonates may be a fraction of 
“normal” levels for adults.  It is also possible that low fetal levels of vitamin D do not manifest 
clinically until later in life, or that a larger study may discover associations between vitamin D 
status and neonatal outcomes.  Research that establishes the clinical relevance of low cord blood 
vitamin D levels will shed light on both age-specific reference ranges for vitamin D levels and 
our general understanding of vitamin D in physiology. 
  In conclusion, this study highlights a growing awareness that vitamin D deficiency and 
insufficiency is a prevalent problem with a relatively simple solution.  Low newborn vitamin D 
levels are only the proverbial “tip of the iceberg” as vitamin D deficiency and insufficiency are 
pervasive throughout life.   Healthy diets, sun exposure and vitamin D supplementation may be 
the “wonder-drugs” of the future.  Multidisciplinary teams including nutritionists, dieticians, 
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nurses, physicians, and teachers will be needed to effect change in both supplementation 
guidelines and public attitudes.  Setting up a newborn for a healthy future begins at conception, 
but we must collaborate to maintain health throughout infancy, childhood and beyond. 
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INTRODUCTION 
 
You are invited to take part in this research study because you will be delivering your baby prior to May 
2012.  
 
Your participation is voluntary. It is up to you to decide whether or not you wish to take part. If you wish 
to participate, you will be asked to sign this form. If you do decide to take part in this study, you are still 
free to withdraw at any time and without giving any reasons for your decision. 
If you do not wish to participate, you will not lose the benefit of any medical care to which you are 
entitled or are presently receiving.  
 
Please take time to read the following information carefully. You can ask the researcher to explain any 
words or information that you do not clearly understand. You may ask as many questions as you need. 
Please feel free to discuss this with your family, friends or family physician before you decide. 
 
WHO IS CONDUCTING THE STUDY?  
 
This study is being conducted by researchers at the University of Saskatchewan, Dr. Alan 
Rosenberg, a pediatrician, Dr. Susan Whiting, a nutritionist, and Dr. Miriam Katzman, a graduate 
student. 
 
WHY IS THIS STUDY BEING DONE? 
We are studying vitamin D levels in newborns to help us understand how common low vitamin D levels 
are, why some newborns are at higher risk of having low vitamin D levels, and what effect a low vitamin 
D level has on a newborn’s health. 
Saskatchewan newborns might be at risk of having low vitamin D levels. During pregnancy, you could 
have low Vitamin D levels because the ultraviolet B rays from the sunlight during Saskatchewan’s winter 
months are not intense enough to activate Vitamin D in your skin.  Diet and genetics can also affect 
Vitamin D levels in you and your newborn baby.  We don’t know how many Saskatchewan newborns 
have low vitamin D levels or what a low level would mean for your baby, but normal vitamin D levels 
may be important for ensuring the health of your baby.  The results of this research may help prevent low 
vitamin D levels and any health risks associated with them. 
 
In this study we aim to answer the following questions: 
 
1. How common are low vitamin D levels in newborns delivered in the Saskatoon Health Region? 
2. Why are some newborns at a higher risk for having a low vitamin D level than others? 
3. What effect does a low vitamin D level have on a newborn’s health? 
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WHO CAN PARTICIPATE IN THE STUDY?  
 
You are eligible to participate in this study if: 
• You are 18 years of age or older  
• You will be delivering your baby at the Royal University Hospital prior to May, 2012 
• You have a single pregnancy (not twins or triplets) 
 
You may not participate if:  
• You have thyroid or parathyroid problems         
• You have problems with calcium regulation  
• You take any medications that interfere with calcium regulation (such as diuretics or calcium 
channel blockers);  
• If you are unsure of whether your medication is a diuretic or calcium channel blocker, please ask! 
WHAT DOES THE STUDY INVOLVE? 
Your participation in this study will take approximately 20 minutes of your time.  
 
If you decide to participate, you will be asked to:  
• Fill out a short questionnaire. You do not have to respond to any questions that you are 
uncomfortable answering.   
• Allow the researchers to access your and your newborn’s health records to get information about 
this pregnancy and delivery 
• Allow the researchers to measure your baby’s skin tone using a device that is placed for several 
seconds on the baby’s arm. 
• Allow the researchers to take a sample of your newborn’s cord blood*                     
*Cord blood is blood taken from the leftover umbilical cord after it is cut.  Cord blood samples are 
normally taken by hospital staff.  We would like to use a sample of cord blood to determine your 
newborn’s vitamin D level. 
 
Your medical information will be protected: You will assigned a Project ID number and all of the 
medical information collected from the questionnaire, health records and cord blood sample will be 
entered into an electronic database under this number.  Only members of the research team will have 
access to information linking your identity with your project ID number.  Your identity will be protected 
in all published material.   
 
The information collected would include: 
 
Information collected prior to delivery: 
• Age 
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• Marital status 
• The first three characters of your postal code 
• Ethnic group 
• Education level 
• Occupation 
• Household income 
• Parity (number of pregnancies you have had) 
• Quantity and frequency of vitamin D supplementation you have taken during your pregnancy  
• Height and weight before you became pregnant  
• Medical conditions you had prior to becoming pregnant 
Information collected after delivery: 
• Medical problems during pregnancy 
• Weight gain during pregnancy 
• Gestation (if your baby was born at the expected time) 
• Method of delivery 
• Complications of delivery 
• Infant length, weight and head circumference 
• Apgar score (a measure of newborn health) 
• Infant medical problems 
• Infant skin reflectance (skin tone) 
• Infant vitamin D level 
WHAT ARE THE BENEFITS OF PARTICIPATING IN THIS STUDY?  
 
There may be no direct benefits to you.  We expect that the information gained from this study will help 
provide advice to women and health care providers about vitamin D supplementation during pregnancy.  
We will also gain a better understanding of whether vitamin D has a role in ensuring the health of 
newborn babies. 
 
ARE THERE POSSIBLE RISKS AND DISCOMFORTS? 
 
There are no risks to participating in this study. 
 
WHAT HAPPENS IF I DECIDE TO WITHDRAW? 
 
Your participation in this research is voluntary. You may withdraw from this study at any time. You do 
not have to provide a reason. Your medical care will not be affected.  Please contact the researchers via 
phone to withdraw. 
 
If you choose to enter the study and then decide to withdraw later, all data collected about you during 
your enrolment will be retained for analysis.  
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WILL I BE INFORMED OF THE RESULTS OF THE STUDY? 
 
If you would like to be informed of the results of the vitamin D level that is obtained on your baby’s cord 
blood as part of this research study and if you would like us to inform your child’s primary care physician 
(such as your child’s family doctor or pediatrician) of the results, you may indicate this in the “Consent to 
Participate” section at the end of this document.  
 
The results of the study will be available by January, 2013 on www.newbornvitamind.com.  As well, the 
results will be published in a Master’s of Health Science thesis paper. 
 
WILL I BE REIMBURSED FOR PARTICIPATING? 
 
You will not be charged for any research-related procedures. You will not be paid for 
participating in this study. You will not receive any compensation, or financial benefits for being 
in this study, or as a result of data obtained from research conducted under this study.  
 
WILL MY TAKING PART IN THIS STUDY BE KEPT CONFIDENTIAL? 
 
In Saskatchewan, the Health Information Protection Act (HIPA) protects the privacy of your personal 
health information. 
 
Your confidentiality will be respected.  No information that discloses your identity will be released or 
published without your specific consent to the disclosure.  However, research records and medical records 
identifying you may be inspected in the presence of the Investigator and the University of Saskatchewan 
Research Ethics Board for the purpose of monitoring the research. However, no records, which identify 
you by name or initials, will be allowed to leave the Investigators' offices. The results of this study may 
be presented in a scientific meeting or published, but your identity will not be disclosed. 
 
WHO DO I CONTACT IF I HAVE QUESTIONS ABOUT THE STUDY? 
 
If you have any questions or desire further information about this study before or during participation, 
you can refer to www.newbornvitamind.com or contact study personnel at info@newbornvitamind.com 
or the Vitamin D Study Office at 306-966-7608. 
 
If you have any concerns about your rights as a research participant and/or your experiences while 
participating in this study, contact the Chair of the University of Saskatchewan Research Ethics Board, at 
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306-966-2975. The Research Ethics Board is a group of individuals (scientists, physicians, ethicists, 
lawyers and members of the community) that provide an independent review of human research studies. 
This study has been reviewed and approved on ethical grounds by the University of Saskatchewan 
Research Ethics Board.  
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CONSENT TO PARTICIPATE 
 
Study Title: Association of Newborn Vitamin D Status with Pregnancy Outcome and 
Infant Health 
 
• I have read (or someone has read to me) the information in this consent form. 
• I understand the purpose and procedures and the possible risks and benefits of the study.  
• I was given sufficient time to think about it. 
• I had the opportunity to ask questions and have received satisfactory answers. 
• I understand that I am free to withdraw from this study at any time for any reason and the 
decision to stop taking part will not affect my future relationships. 
• I give permission to the use and disclosure of my de-identified information collected for 
the research purposes described in this form. 
• I understand that by signing this document I do not waive any of my legal rights. 
• I understand I will be given a signed copy of this consent. 
 
 
I would like the researchers to contact me with the results of my child’s cord blood vitamin D level:  
□ Yes 
□ No 
If you answered “Yes”: 
Please provide your name and address:  
           Name:____________________________________________  
          Address: __________________________________________ 
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I would like the researchers to contact my child’s primary care physician with the results of my child’s cord 
blood vitamin D level: 
□ Yes 
□ No 
If you answered “Yes”: 
Please provide your child’s physician’s name and address:  
           Physician’s Name:____________________________________________  
           Physician’s Address: __________________________________________ 
 
I agree to be contacted for possible future studies related to vitamin D in infants and children: 
□ Yes 
□ No 
 
 
I agree to participate in this study: 
 
 
____________________________________________________________________________ 
Printed name of participant:                      Signature          Date  
 
____________________________________________________________________________ 
Printed name of person obtaining consent:    Signature    Date  
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Study Questionnaire for Participants                                                          Date of 
Enrolment: 
Project ID number: 
You do not have to answer any questions that you feel uncomfortable answering                      .    
Age: 
 
Marital Status: 
  □ Married 
  □ Single 
  □ Divorced 
  □ Separated 
  □ Common-law 
  □ Widowed 
 
Forward Sortation Area (first 3 characters of postal code): 
Maximum Education level: 
  □ Elementary 
  □ High School  
  □ Some university 
  □ Technical training beyond high school 
  □ One or more university degrees 
  □ Other (specify) _____________ 
 
Household income: 
  □ Less than $10,000 
  □ Between $10,000 and $25,000 
  □ Between $25,001 and $50,000 
  □ Between $50,001 and $100,000 
  □ More than $100,000 
Number of previous births (not including current): 
 
Height (ft/inch): 
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Pre-pregnancy weight (lb): 
 
Do you take additional vitamin D supplements?  If yes: 
  How much vitamin D do you take?: 
  How many times per day?: 
  How long have you been taking vitamin D supplements?: 
 
Ethnic group: 
Low levels of vitamin D might be more common in newborns of certain ethnic groups.  Please 
place an ‘X’ in the box or boxes that will best describe your newborn’s origin/descent. 
□ British 
Isles origins 
□ Other 
North 
American 
origins 
□ Canadian □ European 
origins 
□ English □ French 
origins 
□ French □ Scottish □ Western 
European 
origins 
□ Irish □ German □ Eastern 
European 
origins 
□ Southern 
European 
origins 
□ East and 
Southeast 
Asian 
origins 
□ Aboriginal 
origins 
□ Italian □ Chinese □ South 
Asian 
origins 
□ American 
Indian 
□ Ukrainian □ Northern 
European 
origins 
□ Dutch 
(Netherlands) 
□Scandinavian 
origins 
□ Polish 
□ East 
Indian 
□ Caribbean 
origins 
□ Russian □ Arab 
origins 
□ Welsh 
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Mother’s Occupation: 
  □ Management Occupations 
  □ Business, Finance and Administrative Occupations 
  □ Natural and Applied Sciences and Related Occupations 
  □ Health Occupations 
  □ Occupations in Social Science, Education, Government Service and Religion 
  □ Occupations in Art, Culture, Recreation and Sport 
  □ Sales and Service Occupations 
  □ Trades, Transport and Equipment Operators and Related Occupations 
  □ Occupations Unique to Primary Industry 
  □ Occupations Unique to Processing, Manufacturing and Utilities 
  □ Student 
  □ Other ________________ 
 
Please list any pre-pregnancy medical conditions: 
 
 
Have you had any infections or illnesses during your pregnancy? 
  □ Yes 
  □ No 
If yes, please specify and indicate how many months pregnant at the time: 
____________________________________________________________ 
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Recruitment Materials 
 
 
 
 
 
Thank you very much for your interest in the Newborn Vitamin D Study.  I am enclosing copies 
of the information sheet, questionnaire and consent form for your review.  These will provide 
you with detailed information about the study purpose and procedures.  Letters for your doctor 
and delivery nurse have also been included.  
You will have time to consider the information and may contact our research staff with any 
questions or to participate in the study.   
Congratulations and best wishes with the new member of your family! 
Sincerely, 
 
 
Miriam Katzman, MD 
Newborn Vitamin D Study Research Team 
Vitamin D Study Office: (306) 966-7608 
Email: info@newbornvitamind.com 
www.newbornvitamind.com  
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The Newborn Vitamin D Study: 
Information for pregnant women interested in participating 
What is the purpose of this research? 
Our study aims to answer three questions: 
1. How common are low vitamin D levels in newborns delivered in the Saskatoon Health 
Region? 
2. Why are some newborns at a higher risk for having a low vitamin D level than others? 
3. What effect does a low vitamin D level have on a newborn’s health? 
Why is this study important? 
This study will help to determine how frequently low vitamin D levels are found in newborns 
and if there is an association between vitamin D levels at birth and the health of the baby in the 
newborn period. 
Who is performing this study? 
This study is being conducted by researchers at the University of Saskatchewan, Dr. Alan 
Rosenberg and Dr. Susan Whiting and a graduate student, Dr. Miriam Katzman.   
Who can participate in this study? 
You are eligible to participate in this study if you are over 18 years old, have a single pregnancy 
(not twins or triplets) and will be delivering at the Royal University Hospital prior to May, 2012.   
What will the people participating in the study be asked to do? 
Participating takes about 20 minutes of your time.  If you decide to participate in the study, you 
will be asked to fill out a short questionnaire, allow the researchers to access your and your 
newborn’s health records that relate to your pregnancy, delivery and health of your baby at birth, 
allow the researchers to measure your baby’s skin tone, and allow the researchers to take a 
sample of your newborn’s cord blood.   
Who can I contact for more information about this study? 
If you have any questions or are interested in participating, please contact:  
Dr. Miriam Katzman, Graduate Student, or Shauna Richards, Study Nurse 
Email: info@newbornvitamind.com   Website: www.newbornvitamind.com  Phone: 306-966-
7608 
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Dear Nurse, 
Your patient has consented to participate in the Newborn Vitamin D Study.  We would very much 
appreciate it if you would collect a 3cc sample of venous cord blood in the 3mL vacutainer tubes intended 
for this study and store the sample in the study fridge behind the G wing desk in Labour and Delivery.  
Please contact myself, the study administrator, Miriam Katzman, at 716-1937, once this participant has 
delivered her newborn.  As a thank-you for your participation, you may enter your name into a monthly 
draw to win a Starbucks card.  The draw box is located next to the study fridge. 
Thank you very much for your help,    
Miriam Katzman, MD 
Graduate Student, Newborn Vitamin D Research Team 
Email: info@newbornvitamind.com 
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Date  
 
Dear Dr.  
 
Re:   Patient Name 
         DOB:     PHN: 
 Address: 
 Parent Name: 
 Phone Number:  
        Newborn Vitamin D Study Participant (Study ID#       ) 
Your patient, identified above, is a participant in a research study titled: Association of Newborn Vitamin 
D Status with Pregnancy Outcome and Infant Health.  
The purpose of this study is to determine vitamin D status in a population of newborns, to identify factors 
that influence vitamin D levels, and to determine whether a low vitamin D status is associated with any 
adverse neonatal outcomes.  In Saskatchewan, and other northern latitude locations, vitamin D deficiency 
is an increasing concern.  
This letter is to inform you that we have received permission from your patient to participate in the study.  
If she wishes, the results of the vitamin D test will be mailed to you. 
Further information about this study can be found on the study’s website (www.newbornvitamind.com).   
Please do not hesitate to contact me if you have any questions or suggestions relating to this research.   
Yours truly, 
Alan M. Rosenberg M.D. 
Professor of Pediatrics 
Royal University Hospital 
 
 
Dr. Alan M. Rosenberg 
Department of Pediatrics 
Royal University Hospital 
103 Hospital Drive 
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APPENDIX B: Newborn Vitamin D Study: Cord Blood 25(OH)D Levels 
Table B.1. Cord blood 25(OH)D levels (nmol/L) 
17.46 65.28 
21.53 66.36 
27.63 67.11 
30.65 67.29 
33.14 67.37 
33.73 67.47 
37.34 70.36 
37.54 71.62 
44.63 72.54 
44.80 73.38 
45.54 74.13 
45.92 74.85 
47.99 75.05 
48.62 76.13 
50.16 77.01 
50.23 77.42 
50.23 79.67 
51.68 80.29 
51.89 80.42 
53.94 80.62 
54.23 80.73 
55.15 81.03 
56.10 81.65 
58.55 85.70 
58.66 88.97 
60.55 89.49 
60.56 92.50 
61.12 95.12 
61.49 95.85 
61.76 98.59 
62.33 104.01 
62.51 106.29 
64.21 
 
 
 
